data_2hid_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hid _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 14' ' ' ILE . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 55' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.7 p80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 61' ' ' ILE . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.2 p80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD2' ' OXT' ' A' ' 88' ' ' GLU . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.4 p80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.241 0.543 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.422 ' CD1' HD13 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' CG2' ' CB ' ' A' ' 59' ' ' ALA . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 61' ' ' ILE . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 55' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 55' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 14' ' ' ILE . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 55' ' ' ILE . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 24' ' ' GLN . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' N ' HG11 ' A' ' 23' ' ' VAL . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 37' ' ' TYR . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 63' ' ' ILE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.0 p80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 63' ' ' ILE . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.071 0.462 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.9 p80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 61' ' ' ILE . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 37' ' ' TYR . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD2' HG12 ' A' ' 55' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 37' ' ' TYR . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 61' ' ' ILE . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 55' ' ' ILE . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 55' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 6' ' ' PHE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 14' ' ' ILE . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 55' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 6' ' ' PHE . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 14' ' ' ILE . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 43.31 -164.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 55' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.44 176.81 8.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.629 -0.669 . . . . 0.0 109.344 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.268 0.556 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.08 -171.23 2.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.57 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.7 p80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 61' ' ' ILE . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.08 0.467 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -177.75 151.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.2 p80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -131.0 -176.55 4.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.615 -0.678 . . . . 0.0 109.468 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD2' ' OXT' ' A' ' 88' ' ' GLU . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.4 p80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.558 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.87 152.76 18.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.198 -0.939 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.422 ' CD1' HD13 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' CG2' ' CB ' ' A' ' 59' ' ' ALA . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 61' ' ' ILE . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 55' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 55' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -177.05 -173.72 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.768 . . . . 0.0 109.556 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 14' ' ' ILE . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 55' ' ' ILE . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -177.1 -172.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.625 -0.672 . . . . 0.0 109.437 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 24' ' ' GLN . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' N ' HG11 ' A' ' 23' ' ' VAL . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 37' ' ' TYR . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 63' ' ' ILE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -171.7 -177.75 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.0 p80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 63' ' ' ILE . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 42.62 -164.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.832 -0.543 . . . . 0.0 111.36 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.9 p80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 61' ' ' ILE . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 37' ' ' TYR . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -177.86 -172.89 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD2' HG12 ' A' ' 55' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 37' ' ' TYR . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 61' ' ' ILE . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -177.12 160.18 1.72 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 55' ' ' ILE . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 55' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 6' ' ' PHE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 14' ' ' ILE . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 55' ' ' ILE . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -179.73 158.56 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.363 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 55' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 6' ' ' PHE . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.173 0.511 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -179.75 -179.51 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 179.92 156.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 1.3 p80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CD2' HG12 ' A' ' 55' ' ' ILE . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 37' ' ' TYR . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.1 p-80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 63' ' ' ILE . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.775 HG21 HD11 ' A' ' 14' ' ' ILE . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 9' ' ' THR . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.807 HD12 HG21 ' A' ' 55' ' ' ILE . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.858 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.721 ' HA ' HG23 ' A' ' 23' ' ' VAL . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.807 HG21 HD12 ' A' ' 14' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.858 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 63' ' ' ILE . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 61' ' ' ILE . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 63' ' ' ILE . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' THR . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 55' ' ' ILE . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.0 p-80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' CE ' ' A' ' 81' ' ' MET . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 45' ' ' LYS . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.564 ' HB1' ' HE2' ' A' ' 45' ' ' LYS . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.812 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 53' ' ' LEU . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 33' ' ' VAL . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HE2' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 42' ' ' VAL . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 14' ' ' ILE . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.812 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.865 HD12 ' CE2' ' A' ' 6' ' ' PHE . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.661 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.438 HG22 ' OE1' ' A' ' 84' ' ' GLU . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.629 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' OE1' HG22 ' A' ' 80' ' ' THR . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 18' ' ' PRO . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 86' ' ' LEU . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' THR . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.048 HD12 HG21 ' A' ' 55' ' ' ILE . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.6 p-80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' HG12 ' A' ' 23' ' ' VAL . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 81' ' ' MET . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 61' ' ' ILE . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.802 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.546 ' H ' HG12 ' A' ' 42' ' ' VAL . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 44' ' ' LEU . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.86 ' O ' HG12 ' A' ' 51' ' ' VAL . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 48' ' ' MET . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 53' ' ' LEU . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 14' ' ' ILE . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.802 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.733 HD12 HD11 ' A' ' 35' ' ' LEU . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 22' ' ' LEU . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 63' ' ' ILE . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 14' ' ' ILE . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 9' ' ' THR . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 13' ' ' GLY . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.7 p-80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.971 HG21 ' HB1' ' A' ' 26' ' ' ALA . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.825 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 53' ' ' LEU . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 23' ' ' VAL . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' SER . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 42' ' ' VAL . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 6' ' ' PHE . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 73' ' ' ALA . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 63' ' ' ILE . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 9' ' ' THR . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p-80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HB3' HD21 ' A' ' 86' ' ' LEU . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.627 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 53' ' ' LEU . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 40' ' ' LYS . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' A' ' 37' ' ' TYR . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.627 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 18' ' ' PRO . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.241 0.543 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 14' ' ' ILE . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 8' ' ' VAL . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 22' ' ' LEU . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.91 HG12 HD13 ' A' ' 44' ' ' LEU . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.053 HD11 HD12 ' A' ' 61' ' ' ILE . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.91 HD13 HG12 ' A' ' 33' ' ' VAL . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.722 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' SER . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 14' ' ' ILE . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 35' ' ' LEU . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.427 ' OG1' HG21 ' A' ' 25' ' ' THR . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 19.2 p-80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 19.2 p-80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 6' ' ' PHE . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.753 ' CE1' HD12 ' A' ' 63' ' ' ILE . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.0 p-80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 23' ' ' VAL . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 33' ' ' VAL . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 61' ' ' ILE . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 61' ' ' ILE . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 46' ' ' SER . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 48' ' ' MET . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 37' ' ' TYR . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 37' ' ' TYR . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.614 ' N ' HD12 ' A' ' 74' ' ' LEU . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 14' ' ' ILE . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 8' ' ' VAL . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 17.6 p-80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 23' ' ' VAL . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 22' ' ' LEU . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' THR . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.857 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG13 HD12 ' A' ' 55' ' ' ILE . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.881 HD12 HG13 ' A' ' 50' ' ' VAL . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 6' ' ' PHE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 13' ' ' GLY . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB3' ' A' ' 44' ' ' LEU . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 23' ' ' VAL . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 53' ' ' LEU . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.071 0.462 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 14' ' ' ILE . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 8' ' ' VAL . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.5 p-80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.641 ' CG1' HD22 ' A' ' 44' ' ' LEU . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 42' ' ' VAL . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.592 ' OH ' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.688 ' N ' HD12 ' A' ' 74' ' ' LEU . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CE2' HD12 ' A' ' 63' ' ' ILE . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 9' ' ' THR . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 55' ' ' ILE . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p-80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.605 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' HG21 ' A' ' 80' ' ' THR . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 26' ' ' ALA . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 HD12 ' A' ' 61' ' ' ILE . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 61' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.604 HD12 ' H ' ' A' ' 47' ' ' ILE . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 53' ' ' LEU . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 14' ' ' ILE . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.89 HD12 HD11 ' A' ' 35' ' ' LEU . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.694 HD12 ' CE2' ' A' ' 6' ' ' PHE . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.685 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.503 HG21 ' OG1' ' A' ' 25' ' ' THR . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 14' ' ' ILE . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 55' ' ' ILE . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 26' ' ' ALA . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 23' ' ' VAL . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 14' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 HD11 ' A' ' 63' ' ' ILE . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 61' ' ' ILE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.648 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.1 p-80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.5 p-80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG2' HD11 ' A' ' 14' ' ' ILE . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' THR . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.613 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 23' ' ' VAL . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.892 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.892 HG21 ' HB1' ' A' ' 26' ' ' ALA . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 63' ' ' ILE . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' CD1' HG22 ' A' ' 61' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.564 ' H ' HG12 ' A' ' 42' ' ' VAL . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HG23 ' A' ' 33' ' ' VAL . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.586 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 53' ' ' LEU . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 14' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 37' ' ' TYR . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 35' ' ' LEU . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.522 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD1' HD12 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 9' ' ' THR . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.086 HD12 HG21 ' A' ' 55' ' ' ILE . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 47' ' ' ILE . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 22' ' ' LEU . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.831 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG21 ' HB1' ' A' ' 26' ' ' ALA . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 61' ' ' ILE . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.661 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' SER . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 14' ' ' ILE . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 35' ' ' LEU . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 63' ' ' ILE . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 9' ' ' THR . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 55' ' ' ILE . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.59 ' CD2' ' HB3' ' A' ' 17' ' ' ARG . 1.1 p-80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.59 ' HB3' ' CD2' ' A' ' 15' ' ' HIS . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.707 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' HD21 ' A' ' 77' ' ' LEU . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 53' ' ' LEU . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 44' ' ' LEU . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HA ' HG23 ' A' ' 23' ' ' VAL . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB3' ' A' ' 19' ' ' ALA . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 42' ' ' VAL . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 14' ' ' ILE . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 6' ' ' PHE . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 25' ' ' THR . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.5 p-80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.1 p-80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 43.31 -164.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 63' ' ' ILE . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.775 HG21 HD11 ' A' ' 14' ' ' ILE . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 9' ' ' THR . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.807 HD12 HG21 ' A' ' 55' ' ' ILE . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.858 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.721 ' HA ' HG23 ' A' ' 23' ' ' VAL . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.807 HG21 HD12 ' A' ' 14' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.858 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 63' ' ' ILE . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 61' ' ' ILE . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.631 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.44 176.81 8.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.629 -0.669 . . . . 0.0 109.344 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 63' ' ' ILE . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' THR . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 55' ' ' ILE . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.0 p-80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' CE ' ' A' ' 81' ' ' MET . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 45' ' ' LYS . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.564 ' HB1' ' HE2' ' A' ' 45' ' ' LYS . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.812 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 53' ' ' LEU . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 33' ' ' VAL . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HE2' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 42' ' ' VAL . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 14' ' ' ILE . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.812 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.865 HD12 ' CE2' ' A' ' 6' ' ' PHE . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.661 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.438 HG22 ' OE1' ' A' ' 84' ' ' GLU . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.629 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' OE1' HG22 ' A' ' 80' ' ' THR . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 18' ' ' PRO . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.268 0.556 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.08 -171.23 2.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.57 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 86' ' ' LEU . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' THR . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.048 HD12 HG21 ' A' ' 55' ' ' ILE . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.6 p-80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' HG12 ' A' ' 23' ' ' VAL . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 81' ' ' MET . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 61' ' ' ILE . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.802 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.546 ' H ' HG12 ' A' ' 42' ' ' VAL . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 44' ' ' LEU . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.86 ' O ' HG12 ' A' ' 51' ' ' VAL . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 48' ' ' MET . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 53' ' ' LEU . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 14' ' ' ILE . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.802 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.733 HD12 HD11 ' A' ' 35' ' ' LEU . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 22' ' ' LEU . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.08 0.467 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -177.75 151.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 63' ' ' ILE . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 14' ' ' ILE . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 9' ' ' THR . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 13' ' ' GLY . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.7 p-80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.971 HG21 ' HB1' ' A' ' 26' ' ' ALA . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.825 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 53' ' ' LEU . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 23' ' ' VAL . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' SER . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 42' ' ' VAL . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 6' ' ' PHE . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 73' ' ' ALA . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -131.0 -176.55 4.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.615 -0.678 . . . . 0.0 109.468 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 63' ' ' ILE . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 9' ' ' THR . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p-80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HB3' HD21 ' A' ' 86' ' ' LEU . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.627 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 53' ' ' LEU . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 40' ' ' LYS . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' A' ' 37' ' ' TYR . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.627 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 18' ' ' PRO . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.558 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.87 152.76 18.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.198 -0.939 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 14' ' ' ILE . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 8' ' ' VAL . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 22' ' ' LEU . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.91 HG12 HD13 ' A' ' 44' ' ' LEU . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.053 HD11 HD12 ' A' ' 61' ' ' ILE . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.91 HD13 HG12 ' A' ' 33' ' ' VAL . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.722 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' SER . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 14' ' ' ILE . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 35' ' ' LEU . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.427 ' OG1' HG21 ' A' ' 25' ' ' THR . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 19.2 p-80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 19.2 p-80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -177.05 -173.72 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.768 . . . . 0.0 109.556 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 6' ' ' PHE . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.753 ' CE1' HD12 ' A' ' 63' ' ' ILE . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.0 p-80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 23' ' ' VAL . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 33' ' ' VAL . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 61' ' ' ILE . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 61' ' ' ILE . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 46' ' ' SER . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 48' ' ' MET . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 37' ' ' TYR . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 37' ' ' TYR . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.614 ' N ' HD12 ' A' ' 74' ' ' LEU . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -177.1 -172.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.625 -0.672 . . . . 0.0 109.437 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 14' ' ' ILE . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 8' ' ' VAL . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 17.6 p-80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 23' ' ' VAL . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 22' ' ' LEU . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' THR . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.857 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG13 HD12 ' A' ' 55' ' ' ILE . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.881 HD12 HG13 ' A' ' 50' ' ' VAL . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 6' ' ' PHE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.599 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.49 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -171.7 -177.75 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 13' ' ' GLY . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB3' ' A' ' 44' ' ' LEU . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 23' ' ' VAL . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 53' ' ' LEU . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 42.62 -164.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.832 -0.543 . . . . 0.0 111.36 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 14' ' ' ILE . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 8' ' ' VAL . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 2.5 p-80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.641 ' CG1' HD22 ' A' ' 44' ' ' LEU . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 42' ' ' VAL . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.592 ' OH ' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.688 ' N ' HD12 ' A' ' 74' ' ' LEU . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -177.86 -172.89 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CE2' HD12 ' A' ' 63' ' ' ILE . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 9' ' ' THR . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 55' ' ' ILE . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p-80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.605 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' HG21 ' A' ' 80' ' ' THR . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 26' ' ' ALA . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 HD12 ' A' ' 61' ' ' ILE . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 61' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.604 HD12 ' H ' ' A' ' 47' ' ' ILE . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 53' ' ' LEU . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 14' ' ' ILE . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.89 HD12 HD11 ' A' ' 35' ' ' LEU . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.694 HD12 ' CE2' ' A' ' 6' ' ' PHE . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.685 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.503 HG21 ' OG1' ' A' ' 25' ' ' THR . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.869 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -177.12 160.18 1.72 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 14' ' ' ILE . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 55' ' ' ILE . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 26' ' ' ALA . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 23' ' ' VAL . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 14' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 HD11 ' A' ' 63' ' ' ILE . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 61' ' ' ILE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.869 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.648 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.1 p-80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.5 p-80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.667 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -179.73 158.56 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.363 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG2' HD11 ' A' ' 14' ' ' ILE . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' THR . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.613 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 23' ' ' VAL . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.892 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.892 HG21 ' HB1' ' A' ' 26' ' ' ALA . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 63' ' ' ILE . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' CD1' HG22 ' A' ' 61' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' H ' HG12 ' A' ' 42' ' ' VAL . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HG23 ' A' ' 33' ' ' VAL . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.586 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 53' ' ' LEU . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 14' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 37' ' ' TYR . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 35' ' ' LEU . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.522 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.173 0.511 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -179.75 -179.51 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD1' HD12 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 9' ' ' THR . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.086 HD12 HG21 ' A' ' 55' ' ' ILE . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 47' ' ' ILE . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 22' ' ' LEU . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.831 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG21 ' HB1' ' A' ' 26' ' ' ALA . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 61' ' ' ILE . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.661 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' SER . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 14' ' ' ILE . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 35' ' ' LEU . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 179.92 156.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 63' ' ' ILE . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 9' ' ' THR . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 55' ' ' ILE . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.59 ' CD2' ' HB3' ' A' ' 17' ' ' ARG . 1.1 p-80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.59 ' HB3' ' CD2' ' A' ' 15' ' ' HIS . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.707 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' HD21 ' A' ' 77' ' ' LEU . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 53' ' ' LEU . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 44' ' ' LEU . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HA ' HG23 ' A' ' 23' ' ' VAL . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB3' ' A' ' 19' ' ' ALA . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 42' ' ' VAL . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 14' ' ' ILE . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 6' ' ' PHE . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 25' ' ' THR . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 22.5 p-80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.667 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 63' ' ' ILE . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.775 HG21 HD11 ' A' ' 14' ' ' ILE . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 9' ' ' THR . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.807 HD12 HG21 ' A' ' 55' ' ' ILE . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.858 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.721 ' HA ' HG23 ' A' ' 23' ' ' VAL . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.807 HG21 HD12 ' A' ' 14' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.858 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 63' ' ' ILE . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 61' ' ' ILE . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 63' ' ' ILE . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' THR . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 55' ' ' ILE . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' CE ' ' A' ' 81' ' ' MET . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 45' ' ' LYS . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.564 ' HB1' ' HE2' ' A' ' 45' ' ' LYS . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.812 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 53' ' ' LEU . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 33' ' ' VAL . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HE2' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 42' ' ' VAL . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 14' ' ' ILE . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.812 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.865 HD12 ' CE2' ' A' ' 6' ' ' PHE . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.661 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.438 HG22 ' OE1' ' A' ' 84' ' ' GLU . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.629 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' OE1' HG22 ' A' ' 80' ' ' THR . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 18' ' ' PRO . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 86' ' ' LEU . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' THR . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.048 HD12 HG21 ' A' ' 55' ' ' ILE . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.7 p80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' HG12 ' A' ' 23' ' ' VAL . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 81' ' ' MET . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 61' ' ' ILE . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.802 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.546 ' H ' HG12 ' A' ' 42' ' ' VAL . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 44' ' ' LEU . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.86 ' O ' HG12 ' A' ' 51' ' ' VAL . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 48' ' ' MET . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 53' ' ' LEU . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 14' ' ' ILE . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.802 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.733 HD12 HD11 ' A' ' 35' ' ' LEU . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 22' ' ' LEU . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 63' ' ' ILE . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 14' ' ' ILE . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 9' ' ' THR . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 13' ' ' GLY . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.2 p80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.971 HG21 ' HB1' ' A' ' 26' ' ' ALA . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.825 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 53' ' ' LEU . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 23' ' ' VAL . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' SER . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 42' ' ' VAL . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 6' ' ' PHE . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 73' ' ' ALA . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 63' ' ' ILE . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 9' ' ' THR . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.4 p80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HB3' HD21 ' A' ' 86' ' ' LEU . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.627 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 53' ' ' LEU . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 40' ' ' LYS . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' A' ' 37' ' ' TYR . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.627 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 18' ' ' PRO . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.241 0.543 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 14' ' ' ILE . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 8' ' ' VAL . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 22' ' ' LEU . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.91 HG12 HD13 ' A' ' 44' ' ' LEU . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.053 HD11 HD12 ' A' ' 61' ' ' ILE . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.91 HD13 HG12 ' A' ' 33' ' ' VAL . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.722 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' SER . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 14' ' ' ILE . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 35' ' ' LEU . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.427 ' OG1' HG21 ' A' ' 25' ' ' THR . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.204 0.526 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 6' ' ' PHE . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.753 ' CE1' HD12 ' A' ' 63' ' ' ILE . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 23' ' ' VAL . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 33' ' ' VAL . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 61' ' ' ILE . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 61' ' ' ILE . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 46' ' ' SER . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 48' ' ' MET . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 37' ' ' TYR . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 37' ' ' TYR . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.614 ' N ' HD12 ' A' ' 74' ' ' LEU . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 14' ' ' ILE . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 8' ' ' VAL . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 23' ' ' VAL . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 22' ' ' LEU . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' THR . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.857 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG13 HD12 ' A' ' 55' ' ' ILE . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.881 HD12 HG13 ' A' ' 50' ' ' VAL . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 6' ' ' PHE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 13' ' ' GLY . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.0 p80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB3' ' A' ' 44' ' ' LEU . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 23' ' ' VAL . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 53' ' ' LEU . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.071 0.462 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 14' ' ' ILE . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 8' ' ' VAL . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.9 p80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.641 ' CG1' HD22 ' A' ' 44' ' ' LEU . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 42' ' ' VAL . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.592 ' OH ' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.688 ' N ' HD12 ' A' ' 74' ' ' LEU . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CE2' HD12 ' A' ' 63' ' ' ILE . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 9' ' ' THR . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 55' ' ' ILE . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' HG21 ' A' ' 80' ' ' THR . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 26' ' ' ALA . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 HD12 ' A' ' 61' ' ' ILE . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 61' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.604 HD12 ' H ' ' A' ' 47' ' ' ILE . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 53' ' ' LEU . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 14' ' ' ILE . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.89 HD12 HD11 ' A' ' 35' ' ' LEU . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.694 HD12 ' CE2' ' A' ' 6' ' ' PHE . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.685 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.503 HG21 ' OG1' ' A' ' 25' ' ' THR . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 14' ' ' ILE . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 55' ' ' ILE . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 26' ' ' ALA . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 23' ' ' VAL . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 14' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 HD11 ' A' ' 63' ' ' ILE . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 61' ' ' ILE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.648 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG2' HD11 ' A' ' 14' ' ' ILE . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' THR . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.613 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 23' ' ' VAL . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.892 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.892 HG21 ' HB1' ' A' ' 26' ' ' ALA . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 63' ' ' ILE . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' CD1' HG22 ' A' ' 61' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.564 ' H ' HG12 ' A' ' 42' ' ' VAL . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HG23 ' A' ' 33' ' ' VAL . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.586 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 53' ' ' LEU . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 14' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 37' ' ' TYR . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 35' ' ' LEU . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.522 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD1' HD12 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 9' ' ' THR . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.086 HD12 HG21 ' A' ' 55' ' ' ILE . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 47' ' ' ILE . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.51 HG22 ' NE2' ' A' ' 24' ' ' GLN . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 22' ' ' LEU . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.51 ' NE2' HG22 ' A' ' 20' ' ' THR . 31.2 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.831 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG21 ' HB1' ' A' ' 26' ' ' ALA . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 61' ' ' ILE . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.661 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' SER . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 14' ' ' ILE . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 35' ' ' LEU . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 63' ' ' ILE . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 9' ' ' THR . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 55' ' ' ILE . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.707 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' HD21 ' A' ' 77' ' ' LEU . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 53' ' ' LEU . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 44' ' ' LEU . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HA ' HG23 ' A' ' 23' ' ' VAL . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB3' ' A' ' 19' ' ' ALA . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 42' ' ' VAL . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 14' ' ' ILE . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 6' ' ' PHE . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 25' ' ' THR . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.167 0.508 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 43.31 -164.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.18 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -178.59 178.74 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -140.88 127.4 20.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.579 -0.701 . . . . 0.0 109.278 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 63' ' ' ILE . 81.4 m-85 -111.89 152.48 27.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.623 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 98.34 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.679 . . . . 0.0 109.468 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.775 HG21 HD11 ' A' ' 14' ' ' ILE . 23.5 t -67.83 120.22 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.61 -0.681 . . . . 0.0 109.684 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 9' ' ' THR . 17.1 m -121.11 22.22 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -68.56 -12.35 61.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.647 -0.658 . . . . 0.0 110.355 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 p -110.34 13.53 22.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.158 -0.964 . . . . 0.0 110.647 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.8 -137.98 44.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.807 HD12 HG21 ' A' ' 55' ' ' ILE . 13.9 mt -125.85 142.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.307 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -143.84 -166.48 2.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.684 . . . . 0.0 109.555 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.88 -17.6 63.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.189 -0.944 . . . . 0.0 111.415 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.6 OUTLIER -62.91 -59.62 12.0 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 109.784 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.96 -21.22 28.21 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.348 1.366 . . . . 0.0 110.512 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.56 -23.51 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.1 m -80.18 -35.79 35.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 109.125 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.67 -30.06 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.25 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.97 -36.96 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.967 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.2 p -67.32 -32.88 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.5 -40.87 80.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.726 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.6 m -69.44 -32.99 72.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.575 -0.703 . . . . 0.0 109.812 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.56 -25.08 60.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -67.63 -27.36 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 110.043 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.79 -17.32 64.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.451 -0.781 . . . . 0.0 110.374 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -115.99 148.51 40.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.33 -9.5 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.77 -0.582 . . . . 0.0 110.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.84 164.51 3.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 109.683 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.74 98.32 11.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.668 -0.645 . . . . 0.0 109.725 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -90.44 143.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.624 -0.672 . . . . 0.0 109.242 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -144.7 146.17 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.743 . . . . 0.0 109.769 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 tp -109.56 118.97 38.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.222 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -105.57 150.58 25.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.683 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.858 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.4 t80 -159.24 133.77 7.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.706 -0.621 . . . . 0.0 109.678 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.08 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.852 -0.53 . . . . 0.0 110.126 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.79 5.52 1.11 Allowed Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.841 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -112.56 142.31 45.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.869 1.334 . . . . 0.0 108.968 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.7 m -116.55 125.1 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.11 -177.75 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -91.18 140.0 30.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.16 -23.8 64.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.606 -0.684 . . . . 0.0 109.549 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.721 ' HA ' HG23 ' A' ' 23' ' ' VAL . 17.7 mtpt -92.72 44.96 1.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.527 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -129.64 131.68 46.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.821 . . . . 0.0 109.508 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.59 -34.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.18 -4.96 45.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.701 . . . . 0.0 110.403 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.8 -26.58 24.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.58 -30.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -1.021 . . . . 0.0 109.837 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.73 -26.7 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.0 109.754 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -64.5 -40.99 96.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.75 -54.61 36.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 109.914 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.06 57.29 3.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.807 HG21 HD12 ' A' ' 14' ' ' ILE . 68.2 mt -67.79 161.43 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.604 -0.939 . . . . 0.0 109.401 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -129.9 -162.74 1.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 155.49 39.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.99 52.52 51.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.858 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -110.47 124.68 52.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.891 . . . . 0.0 109.874 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.59 113.36 23.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 63' ' ' ILE . 23.6 pt -103.75 153.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.712 . . . . 0.0 109.682 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m -125.97 111.15 14.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.674 . . . . 0.0 109.414 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 61' ' ' ILE . 4.7 mp -96.33 124.98 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.9 p -127.17 135.51 50.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.83 136.29 54.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.629 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -141.34 104.8 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.65 -0.656 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.78 -130.54 1.34 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.09 -55.61 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.945 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -100.47 40.5 1.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.55 -0.719 . . . . 0.0 109.366 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.21 -30.62 70.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -67.92 -38.93 83.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.591 -0.693 . . . . 0.0 110.044 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -77.71 -21.43 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.475 -0.765 . . . . 0.0 110.261 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.82 -33.94 34.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.351 -0.843 . . . . 0.0 110.542 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -77.63 -38.91 46.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.272 -0.892 . . . . 0.0 110.529 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.5 p30 -79.0 -26.9 43.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.27 65.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 108.986 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.5 mt -80.47 -28.39 37.6 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -50.72 67.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.51 -40.57 95.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.529 -0.732 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.2 m -64.98 -27.01 68.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.587 -0.696 . . . . 0.0 109.825 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.2 mmt -69.52 -44.26 71.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.487 -0.758 . . . . 0.0 109.656 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -86.48 8.91 19.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.727 . . . . 0.0 110.553 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.6 p -90.4 -30.36 17.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -112.89 -3.03 14.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.659 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.99 49.9 8.24 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.72 -32.9 11.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.569 -0.959 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.8 175.8 39.93 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.503 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.631 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.44 176.81 8.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.629 -0.669 . . . . 0.0 109.344 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.0 172.47 18.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 0.0 109.393 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -130.2 126.97 38.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 63' ' ' ILE . 97.9 m-85 -115.11 125.35 53.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.586 -0.696 . . . . 0.0 109.892 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 109.54 21.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.41 110.52 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.616 -0.678 . . . . 0.0 109.335 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' THR . 23.0 m -104.6 18.05 22.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.662 -0.649 . . . . 0.0 110.029 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.92 137.5 38.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.33 -26.34 68.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 109.819 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -76.46 -31.46 57.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.773 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.3 -133.76 12.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 55' ' ' ILE . 64.2 mt -124.27 120.54 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.925 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -130.18 -166.97 1.75 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.684 . . . . 0.0 109.362 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.55 -20.63 65.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.158 -0.964 . . . . 0.0 111.487 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -65.17 -59.46 9.86 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.099 -1.0 . . . . 0.0 110.059 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.0 Cg_endo -72.06 -21.33 24.16 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.364 1.376 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.78 55.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.435 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.1 m -80.67 -32.56 35.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.459 -0.776 . . . . 0.0 109.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 t -77.98 -30.45 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' CE ' ' A' ' 81' ' ' MET . 64.0 mt -78.11 -36.98 47.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 45' ' ' LYS . 11.5 p -70.19 -30.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.403 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -67.0 -47.32 71.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 m -64.35 -45.71 86.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.672 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.564 ' HB1' ' HE2' ' A' ' 45' ' ' LYS . . . -63.26 -26.89 68.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.133 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 p -65.35 -32.5 74.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 109.288 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.09 -26.9 69.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.694 -0.629 . . . . 0.0 109.572 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.42 136.86 42.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.51 -0.744 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -86.42 -0.26 55.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.676 -0.64 . . . . 0.0 110.516 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -173.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.37 98.47 8.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.57 111.7 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.664 -0.648 . . . . 0.0 109.294 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -116.33 148.99 40.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.797 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.0 tp -114.72 126.91 55.41 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -109.29 148.22 31.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.609 -0.682 . . . . 0.0 109.895 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.812 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 64.1 t80 -160.08 138.32 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 63.78 -85.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 31.56 0.31 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -136.11 143.44 44.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.824 -0.81 . . . . 0.0 109.173 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 m -106.91 116.9 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 53' ' ' LEU . 20.5 m -119.94 165.63 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -71.62 127.94 34.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 33' ' ' VAL . 4.9 tt -61.98 -23.88 66.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.574 -0.704 . . . . 0.0 109.847 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HE2' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -92.53 46.92 1.27 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.445 -0.784 . . . . 0.0 109.543 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -125.44 132.57 52.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mp -99.53 -34.77 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.8 ttp -88.94 -27.33 21.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.528 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 -29.51 72.41 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.27 -29.83 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.564 -0.962 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.44 -37.85 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -71.5 -30.28 65.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.621 -0.674 . . . . 0.0 109.372 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 42' ' ' VAL . 16.1 mt -63.53 -53.2 55.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.565 -0.709 . . . . 0.0 109.562 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.42 54.08 3.24 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 14' ' ' ILE . 53.1 mt -87.94 142.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.594 -0.945 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.53 -169.47 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.718 -0.614 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -60.51 148.22 38.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.931 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.13 50.6 50.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.812 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -109.57 133.94 52.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.683 -0.892 . . . . 0.0 109.594 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -94.76 121.96 36.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 109.317 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.04 154.26 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.797 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 m -130.26 117.73 20.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.865 HD12 ' CE2' ' A' ' 6' ' ' PHE . 87.4 mt -92.18 152.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.697 . . . . 0.0 109.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 p -148.62 116.09 6.22 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.04 140.7 35.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 109.741 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -150.15 104.6 3.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.24 -143.88 6.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.01 -56.0 3.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.574 -0.957 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -99.56 37.46 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.239 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -29.21 69.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 0.0 109.625 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -69.41 -41.45 76.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.715 . . . . 0.0 109.82 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.89 -19.56 60.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.434 -0.791 . . . . 0.0 110.189 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.81 -43.28 20.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.825 . . . . 0.0 110.573 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.42 -40.0 81.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.387 -0.821 . . . . 0.0 110.634 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.661 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -79.36 -26.62 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.72 56.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.738 . . . . 0.0 109.508 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.2 mt -84.27 -27.62 27.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.543 -0.723 . . . . 0.0 109.177 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.85 76.63 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -32.59 71.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.665 -0.647 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.438 HG22 ' OE1' ' A' ' 84' ' ' GLU . 22.9 m -71.13 -26.59 63.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -0.763 . . . . 0.0 109.635 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.629 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -69.97 -57.92 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.029 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -58.09 -32.48 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.421 -0.799 . . . . 0.0 110.374 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -65.85 -34.37 77.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.792 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' OE1' HG22 ' A' ' 80' ' ' THR . 1.9 mp0 -95.22 -2.16 50.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.561 -0.712 . . . . 0.0 110.654 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.54 36.34 93.05 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 18' ' ' PRO . 56.4 mt -94.92 12.28 28.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.938 . . . . 0.0 110.317 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.63 -163.25 21.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.591 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.268 0.556 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.08 -171.23 2.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.57 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -176.49 178.87 1.24 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.702 . . . . 0.0 109.117 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -133.56 126.75 31.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 63' ' ' ILE . 54.3 m-85 -113.96 140.97 47.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.602 -0.686 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -106.89 101.8 11.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.658 . . . . 0.0 109.474 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 86' ' ' LEU . 24.8 t -71.64 113.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.569 -0.707 . . . . 0.0 109.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' THR . 24.8 m -117.62 20.83 13.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.601 -0.687 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 136.82 38.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -71.43 85.89 0.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.765 -0.585 . . . . 0.0 109.692 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 169.65 -35.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.95 -170.89 33.72 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.048 HD12 HG21 ' A' ' 55' ' ' ILE . 53.2 mt -97.78 128.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.495 -1.003 . . . . 0.0 109.358 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.7 p80 -132.72 -167.48 1.91 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.0 64.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.198 -0.939 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -59.85 -58.75 17.13 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.0 110.171 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.5 Cg_endo -72.31 -19.45 25.57 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.333 1.356 . . . . 0.0 110.905 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.95 -27.06 60.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.589 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' HG12 ' A' ' 23' ' ' VAL . 97.2 m -82.64 -32.08 28.43 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.45 -32.99 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 81' ' ' MET . 15.3 mt -75.85 -46.33 30.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.629 -0.67 . . . . 0.0 109.652 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -62.17 -30.6 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.58 -0.7 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -64.38 -55.4 21.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.554 -0.716 . . . . 0.0 109.823 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 m -61.2 -30.17 70.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.595 -0.691 . . . . 0.0 109.951 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.69 -27.32 61.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.523 -0.735 . . . . 0.0 110.165 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.7 m -65.41 -27.18 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.513 -0.742 . . . . 0.0 110.014 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -69.96 -23.5 63.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -107.44 131.84 53.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.46 -3.18 48.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.63 -176.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.28 98.91 8.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.534 -0.729 . . . . 0.0 109.679 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -95.44 113.32 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -115.3 156.93 24.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.736 . . . . 0.0 109.749 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 61' ' ' ILE . 10.2 tp -121.74 126.46 48.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -108.21 146.74 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.802 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 t80 -159.75 137.06 9.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 64.57 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.42 31.86 0.34 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -138.71 142.94 38.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.808 -0.819 . . . . 0.0 109.327 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 m -111.89 129.78 56.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.787 -0.57 . . . . 0.0 109.712 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.5 t -129.89 177.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.546 ' H ' HG12 ' A' ' 42' ' ' VAL . 33.6 t30 -93.77 132.62 37.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 44' ' ' LEU . 26.3 tp -76.29 -3.6 37.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.531 -0.731 . . . . 0.0 110.278 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.7 mttp -83.9 -4.03 58.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.282 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -114.05 127.46 55.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.8 mp -78.97 -38.13 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.86 ' O ' HG12 ' A' ' 51' ' ' VAL . 6.6 tmm? -82.12 -19.81 39.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.693 -0.629 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.41 -23.08 74.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -100.74 9.67 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.282 -1.128 . . . . 0.0 110.736 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 48' ' ' MET . 12.7 p -90.42 -27.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 109.561 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.5 p -62.2 -27.29 68.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.0 109.724 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 53' ' ' LEU . 31.4 mt -61.57 -35.5 77.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.742 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 51.71 47.68 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 14' ' ' ILE . 24.1 mt -77.35 144.95 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.611 -0.935 . . . . 0.0 109.274 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.33 -171.3 2.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -58.5 153.62 15.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.512 -0.743 . . . . 0.0 110.041 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.89 51.99 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.802 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.88 136.83 53.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.595 -0.944 . . . . 0.0 109.693 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -101.53 122.84 44.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.591 -0.693 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.733 HD12 HD11 ' A' ' 35' ' ' LEU . 29.5 pt -119.1 153.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.478 -0.764 . . . . 0.0 109.711 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -121.06 112.85 19.23 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 6' ' ' PHE . 10.3 mt -92.39 137.39 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.489 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -133.74 133.84 42.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.609 -0.682 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.85 134.3 54.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -146.19 103.8 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.65 -141.98 5.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.6 1.96 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.628 -0.925 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -97.04 41.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.666 -0.646 . . . . 0.0 109.426 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -66.82 -25.9 66.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.855 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.31 -41.97 46.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -71.35 -19.66 62.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 110.383 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.77 -43.43 20.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.302 -0.874 . . . . 0.0 110.657 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.6 pp -70.87 -40.48 72.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.878 . . . . 0.0 110.771 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.3 p30 -77.03 -26.41 53.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.171 -0.956 . . . . 0.0 109.938 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.89 -27.82 49.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.37 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.02 -26.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 109.195 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -71.16 -42.47 69.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.64 -29.61 66.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.568 -0.708 . . . . 0.0 109.599 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -77.76 -27.54 50.36 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.585 -0.697 . . . . 0.0 109.726 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 22' ' ' LEU . 2.7 tpt -70.97 -41.89 70.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -80.3 -21.98 42.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.0 p -58.05 -27.54 63.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -112.47 -51.88 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.23 55.27 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.6 mt -96.26 -41.1 8.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.971 . . . . 0.0 109.587 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.32 -173.87 24.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.462 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.08 0.467 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -177.75 151.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.512 -0.742 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.84 172.96 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.677 . . . . 0.0 109.399 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -122.1 125.82 47.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 63' ' ' ILE . 87.8 m-85 -113.12 126.16 55.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.79 106.56 18.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 14' ' ' ILE . 39.7 t -75.97 121.97 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 9' ' ' THR . 4.4 m -122.21 17.21 10.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.739 . . . . 0.0 110.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 139.43 39.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -71.13 86.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.719 -0.613 . . . . 0.0 109.525 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 169.76 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 96.44 -121.91 7.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 13' ' ' GLY . 44.4 mm -137.8 128.0 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.651 -0.911 . . . . 0.0 109.562 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.2 p80 -131.71 -170.2 2.35 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.79 64.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 111.605 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -65.56 -59.11 10.05 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.068 -1.02 . . . . 0.0 109.908 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 34.3 Cg_endo -73.53 -20.94 20.02 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.391 1.394 . . . . 0.0 110.661 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.9 -27.77 57.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.421 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.0 m -80.76 -31.71 35.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.151 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.83 -31.75 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.646 . . . . 0.0 109.425 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.89 -41.14 44.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.646 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.0 p -65.1 -29.08 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.642 -0.661 . . . . 0.0 109.563 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.17 -49.58 55.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.667 -0.646 . . . . 0.0 109.947 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.0 m -61.19 -42.29 98.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.506 -0.746 . . . . 0.0 110.002 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.62 -25.03 62.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 m -66.91 -26.64 66.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.902 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -62.96 -23.11 67.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -109.48 139.37 44.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 109.757 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -79.99 -7.41 58.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.84 169.37 1.01 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.66 97.96 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.811 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.971 HG21 ' HB1' ' A' ' 26' ' ' ALA . 28.5 m -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.661 -0.649 . . . . 0.0 109.365 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -120.16 149.68 41.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.18 121.39 45.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.64 136.83 41.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.614 -0.679 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.825 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 60.5 t80 -158.69 140.15 13.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.703 . . . . 0.0 109.673 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.53 16.34 7.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.677 -0.639 . . . . 0.0 110.772 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.87 -18.21 48.67 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -89.23 142.17 27.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -1.157 . . . . 0.0 109.246 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -102.45 126.63 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.803 -0.56 . . . . 0.0 109.639 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 53' ' ' LEU . 28.4 m -125.06 173.92 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.682 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -90.05 136.53 32.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.559 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.4 tt -76.86 -14.69 59.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 110.255 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 23' ' ' VAL . 19.5 mtpp -90.74 17.86 7.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.62 126.2 53.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.065 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.7 mp -92.48 -37.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.684 . . . . 0.0 109.257 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 8.5 ttm -81.86 -28.42 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.681 -0.637 . . . . 0.0 109.381 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.66 -28.77 73.05 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' SER . 34.5 t -72.15 -26.15 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.984 . . . . 0.0 109.812 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.06 -29.5 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.82 . . . . 0.0 109.713 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 p -74.09 -28.82 61.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.676 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 42' ' ' VAL . 13.6 mt -60.96 -49.75 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 59.12 5.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.3 mt -82.08 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.619 -0.93 . . . . 0.0 109.292 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.12 -176.77 4.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 148.96 44.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.507 -0.746 . . . . 0.0 109.471 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.59 50.67 41.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -107.83 133.36 52.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.643 -0.916 . . . . 0.0 109.597 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -96.85 113.82 25.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.4 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.95 156.03 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.582 -0.699 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -126.39 111.16 14.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.19 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 6' ' ' PHE . 85.3 mt -92.05 137.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.62 -0.675 . . . . 0.0 109.325 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.1 p -139.91 132.58 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.16 140.88 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.497 -0.752 . . . . 0.0 109.787 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -140.23 101.23 4.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.96 -141.23 3.74 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.55 -52.61 4.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.96 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -101.63 41.23 1.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.421 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -62.66 -29.2 70.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.592 -0.692 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.6 m120 -71.33 -41.82 69.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -73.53 -18.91 61.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.513 -0.742 . . . . 0.0 110.284 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -46.92 14.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.496 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -64.58 -41.06 96.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.836 . . . . 0.0 110.748 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.1 p30 -77.22 -27.23 53.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -68.53 -29.84 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 73' ' ' ALA . 4.7 mt -85.12 -23.75 28.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 6.3 tm-20 -70.41 -35.27 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -78.52 -43.48 26.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 109.921 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.8 m -67.33 -26.0 66.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.1 mtt -71.79 -50.92 25.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -0.771 . . . . 0.0 110.377 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -72.46 -24.02 61.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 110.901 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -60.41 -58.8 6.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.253 -0.904 . . . . 0.0 109.846 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.41 -30.41 63.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.53 69.25 1.03 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.9 mt -111.4 -34.25 6.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.946 . . . . 0.0 109.367 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.36 -169.17 23.3 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.411 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -131.0 -176.55 4.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.615 -0.678 . . . . 0.0 109.468 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -167.62 170.65 10.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.665 -0.647 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -127.49 120.93 29.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.562 -0.711 . . . . 0.0 109.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 63' ' ' ILE . 34.8 m-85 -108.63 139.63 43.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.732 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -89.88 105.03 17.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.84 116.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 109.544 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 9' ' ' THR . 25.1 m -119.47 24.15 10.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -61.17 157.93 15.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.396 -0.815 . . . . 0.0 109.692 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.24 -30.17 67.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.728 . . . . 0.0 109.735 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -125.84 27.88 6.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.727 . . . . 0.0 109.916 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 72.03 -125.37 10.95 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.5 mt -131.66 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.998 . . . . 0.0 109.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.4 p80 -121.56 -167.49 1.53 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 -24.2 67.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.11 -0.993 . . . . 0.0 111.455 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 3.7 mtt180 -62.21 -60.35 10.35 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.014 -1.054 . . . . 0.0 109.856 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HB3' HD21 ' A' ' 86' ' ' LEU . 34.1 Cg_endo -72.24 -13.36 28.25 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.307 1.338 . . . . 0.0 110.744 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.41 43.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.5 m -80.46 -34.2 36.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.086 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.42 -31.05 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.489 -0.757 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.2 mt -75.44 -41.61 55.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 109.741 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.6 p -63.42 -32.69 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.755 . . . . 0.0 109.432 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.63 -47.41 75.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.614 -0.678 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.9 m -61.26 -42.78 99.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.605 -0.684 . . . . 0.0 110.041 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -65.6 -29.33 69.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 t -67.73 -27.51 66.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -23.6 66.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -110.64 132.77 53.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 109.693 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.85 -11.67 60.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.749 -0.594 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.98 156.27 9.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -89.88 100.34 13.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.733 . . . . 0.0 109.725 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 26' ' ' ALA . 22.4 m -101.41 141.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -143.15 148.17 36.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.8 128.32 44.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.279 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.77 114.79 28.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.548 -0.72 . . . . 0.0 109.692 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.627 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 34.4 t80 -143.76 140.31 29.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.571 -0.706 . . . . 0.0 109.578 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.16 33.03 17.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.08 30.32 75.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 53' ' ' LEU . 17.5 mtpp -127.68 143.68 51.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.725 -0.868 . . . . 0.0 109.118 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -111.28 125.38 53.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.631 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.06 152.84 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.642 -0.661 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -63.31 138.74 58.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 109.7 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.42 -31.02 72.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.4 mtpp -89.81 52.13 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.481 -0.762 . . . . 0.0 109.684 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -131.7 131.1 42.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.501 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.56 -30.69 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -31.06 16.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.544 -0.722 . . . . 0.0 109.102 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.82 -29.15 74.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.52 -29.45 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.982 . . . . 0.0 109.486 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.93 -29.48 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 109.528 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -64.64 -33.1 75.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 40' ' ' LYS . 15.3 mt -73.53 -56.14 5.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.74 59.62 2.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' A' ' 37' ' ' TYR . 55.7 mt -73.49 142.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.664 -0.904 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.74 -178.13 3.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 145.81 55.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.691 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.14 46.68 57.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.627 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -111.19 132.61 54.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.46 -1.023 . . . . 0.0 109.508 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -85.6 120.82 27.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.26 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.5 154.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.701 . . . . 0.0 109.836 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.7 m -128.24 113.66 15.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.661 -0.65 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.4 mp -92.07 144.71 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.184 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.6 p -134.52 119.87 19.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 0.0 109.309 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.72 136.55 50.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.3 m -146.19 102.35 3.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.676 -0.64 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.93 -142.39 4.21 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.2 -45.65 7.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.553 -0.969 . . . . 0.0 109.447 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -100.66 39.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.34 -32.82 72.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.623 -0.673 . . . . 0.0 110.006 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -68.19 -43.4 78.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.517 -0.74 . . . . 0.0 110.065 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 43.6 m-20 -74.39 -19.68 60.34 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.518 -0.739 . . . . 0.0 110.533 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.85 -42.7 23.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.267 -0.896 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.41 -42.93 74.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.0 p30 -75.18 -26.98 59.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -73.71 -27.52 61.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.666 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.36 -30.44 48.0 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -61.19 -55.48 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.36 -33.09 73.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.598 -0.689 . . . . 0.0 109.823 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.0 m -62.01 -36.71 82.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.627 -0.67 . . . . 0.0 109.779 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.8 mmt -69.67 -48.99 57.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -56.13 -21.29 21.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 0.0 110.588 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.6 p -59.53 -42.96 93.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -115.16 13.95 16.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.415 -0.803 . . . . 0.0 110.801 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.75 42.03 99.28 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 18' ' ' PRO . 14.6 mt -81.76 -27.36 33.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.602 -0.94 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 170.41 -169.65 42.45 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' OXT' ' CD2' ' A' ' 6' ' ' PHE . 10.0 pt-20 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.558 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.87 152.76 18.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.198 -0.939 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -142.96 178.32 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.621 -0.674 . . . . 0.0 109.286 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -125.62 128.7 48.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 63' ' ' ILE . 88.7 m-85 -116.85 147.9 41.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.601 -0.687 . . . . 0.0 109.441 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.92 115.1 28.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 14' ' ' ILE . 21.6 t -82.19 132.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 24.9 m -120.33 -2.28 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.577 -0.702 . . . . 0.0 110.62 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.15 57.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 109.413 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.09 -28.39 69.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.807 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -74.19 -29.42 61.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.704 . . . . 0.0 109.762 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.69 -133.77 12.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 8' ' ' VAL . 55.4 mt -126.15 94.68 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.481 -1.011 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.9 p80 -110.13 -165.58 1.02 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.73 69.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.021 -1.049 . . . . 0.0 111.774 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -62.2 -60.38 10.28 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.005 -1.059 . . . . 0.0 110.135 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -71.61 -16.32 30.31 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.91 -27.41 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.193 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.3 m -80.69 -34.12 34.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.16 -29.66 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.488 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 22' ' ' LEU . 47.0 mt -80.98 -33.47 33.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.842 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.1 p -72.66 -28.3 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 109.51 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -61.85 -51.71 67.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.56 -26.2 68.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.705 . . . . 0.0 109.882 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -66.74 -27.99 68.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.724 . . . . 0.0 109.705 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -60.93 -25.73 66.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -0.809 . . . . 0.0 109.913 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -104.43 135.42 45.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -0.89 34.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.669 -0.644 . . . . 0.0 110.508 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.1 -174.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -107.46 97.52 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.576 -0.702 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.91 HG12 HD13 ' A' ' 44' ' ' LEU . 21.7 t -93.63 116.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -123.15 157.33 33.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.053 HD11 HD12 ' A' ' 61' ' ' ILE . 2.4 tp -120.15 128.03 53.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.17 121.15 44.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.725 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 31.4 t80 -146.9 140.5 25.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 109.69 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 61.51 36.92 16.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.721 . . . . 0.0 109.773 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.89 29.39 64.77 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -125.74 143.78 50.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.657 -0.908 . . . . 0.0 109.064 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -110.47 123.32 49.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.707 -0.621 . . . . 0.0 109.513 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.69 177.52 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.555 -0.715 . . . . 0.0 109.534 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -90.49 135.96 33.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.616 -0.678 . . . . 0.0 109.513 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.91 HD13 HG12 ' A' ' 33' ' ' VAL . 6.8 tt -75.15 -18.18 60.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 110.186 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.722 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.8 mttp -96.41 28.46 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 109.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 t -122.81 126.86 48.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 109.636 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -84.95 -39.32 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.4 ttt -79.48 -20.03 48.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.73 -0.606 . . . . 0.0 109.73 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.33 -25.66 56.6 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' SER . 39.9 t -87.12 -35.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.44 -1.035 . . . . 0.0 109.764 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.53 -29.16 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.533 -0.729 . . . . 0.0 109.574 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -60.47 -33.55 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mt -73.09 -49.66 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.554 -0.716 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.44 55.33 4.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 14' ' ' ILE . 57.7 mt -74.29 141.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.58 -0.953 . . . . 0.0 109.507 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.0 -174.99 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.784 -0.573 . . . . 0.0 109.695 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 156.14 6.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.51 -0.744 . . . . 0.0 110.261 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 52.8 50.26 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -121.97 124.86 45.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.678 -0.895 . . . . 0.0 109.824 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.48 116.49 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.695 . . . . 0.0 109.323 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 35' ' ' LEU . 32.3 pt -114.61 155.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.383 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 m -121.6 112.58 18.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 109.603 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 6' ' ' PHE . 77.2 mt -92.46 151.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.559 -0.713 . . . . 0.0 109.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 p -139.24 125.99 20.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.679 -0.638 . . . . 0.0 109.387 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.56 120.65 43.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.697 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.27 104.41 5.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.537 -0.727 . . . . 0.0 109.47 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.23 -137.59 2.98 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.04 -55.13 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.541 -0.976 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -98.13 38.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.611 -0.681 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.0 69.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.731 . . . . 0.0 109.78 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.38 -43.29 73.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 109.821 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -18.95 55.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 110.248 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.59 -36.27 33.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.401 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -74.45 -40.88 61.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.305 -0.872 . . . . 0.0 110.439 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.1 p30 -79.24 -26.59 42.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.8 -28.09 60.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.592 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.13 -30.62 39.05 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.05 -54.33 42.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.86 -35.63 77.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.537 -0.727 . . . . 0.0 109.755 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.427 ' OG1' HG21 ' A' ' 25' ' ' THR . 38.1 m -63.0 -32.52 73.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -71.28 -38.24 71.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -93.28 19.03 8.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.562 -0.712 . . . . 0.0 110.189 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -90.56 -37.8 13.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -111.41 -29.37 7.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.603 -0.685 . . . . 0.0 109.686 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 36.6 1.18 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -83.83 -40.58 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.932 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.52 -163.24 21.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.555 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -177.8 151.67 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 109.601 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -128.56 176.15 7.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.1 m -127.49 155.65 43.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.449 -0.782 . . . . 0.0 109.162 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 63' ' ' ILE . 96.6 m-85 -146.91 158.07 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.984 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -115.28 117.54 30.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 14' ' ' ILE . 21.9 t -74.48 137.55 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.761 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' THR . 5.4 m -150.02 22.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.692 -0.63 . . . . 0.0 109.709 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 -169.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 0.0 109.713 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.28 -42.76 71.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.848 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -127.59 29.26 5.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.9 -115.07 3.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG13 HG11 ' A' ' 8' ' ' VAL . 70.3 mt -140.15 115.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.975 . . . . 0.0 109.591 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.3 p80 -122.24 -125.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.377 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.0 -29.64 23.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.327 -1.483 . . . . 0.0 111.53 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 4.4 ttp85 -62.58 -54.7 45.81 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.13 -0.981 . . . . 0.0 110.337 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB3' HD22 ' A' ' 86' ' ' LEU . 35.7 Cg_endo -77.35 -24.31 9.38 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.353 1.368 . . . . 0.0 110.79 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -73.07 -25.98 61.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.869 . . . . 0.0 109.544 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 m -81.74 -38.78 25.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.449 -0.782 . . . . 0.0 109.477 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 18' ' ' PRO . 12.6 p -73.0 -26.99 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.63 -42.18 25.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.1 p -66.08 -31.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.717 . . . . 0.0 109.33 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -49.89 53.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.622 -0.674 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.0 m -61.35 -32.47 72.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.619 -0.676 . . . . 0.0 109.861 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.74 -31.08 63.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 109.669 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.0 -27.48 67.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.77 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -65.04 -23.16 67.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.0 110.022 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -113.11 138.48 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -81.2 -4.69 56.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 110.402 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.73 1.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -100.29 99.2 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG21 ' HB1' ' A' ' 26' ' ' ALA . 18.2 m -94.0 128.28 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.308 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.66 153.98 41.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.479 -0.763 . . . . 0.0 109.692 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 44' ' ' LEU . 12.6 tp -115.38 111.93 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.652 -0.655 . . . . 0.0 109.291 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.38 23.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 61' ' ' ILE . 62.9 t80 -139.56 145.06 38.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.67 -0.644 . . . . 0.0 109.423 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t30 59.53 31.92 21.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.527 -0.733 . . . . 0.0 109.804 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.1 35.51 91.59 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -134.83 143.15 46.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.77 -0.841 . . . . 0.0 109.22 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m -108.41 124.35 50.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.6 t -136.35 176.71 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.562 ' H ' HG12 ' A' ' 42' ' ' VAL . 13.6 t-20 -81.03 139.47 35.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 HD13 ' A' ' 35' ' ' LEU . 55.7 tp -77.84 -19.85 54.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.739 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -94.61 28.46 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.906 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -121.48 127.77 51.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.8 mp -96.66 -35.94 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.708 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.8 tpt -87.48 -12.69 45.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.688 -0.632 . . . . 0.0 110.105 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.07 -36.49 11.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 53' ' ' LEU . 33.4 t -83.68 -6.14 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.95 . . . . 0.0 110.657 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 48' ' ' MET . 10.1 p -61.61 -29.99 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 109.53 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.57 -33.06 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.538 -0.726 . . . . 0.0 109.412 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.717 HD12 HG13 ' A' ' 50' ' ' VAL . 14.9 mt -62.97 -51.79 65.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.7 4.57 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 37' ' ' TYR . 56.2 mt -71.39 141.29 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.967 . . . . 0.0 109.051 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.48 -175.04 3.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.781 -0.574 . . . . 0.0 109.627 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -68.08 155.17 40.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.53 49.91 71.99 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -124.36 168.96 12.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.609 -0.936 . . . . 0.0 109.479 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -123.48 114.34 19.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.531 -0.731 . . . . 0.0 109.541 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG22 ' CD1' ' A' ' 37' ' ' TYR . 4.8 pt -113.19 166.93 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -131.22 154.48 48.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 109.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.5 mt -134.47 137.66 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 p -138.42 123.24 18.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.46 131.07 57.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.502 -0.749 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.2 m -141.83 109.34 5.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.64 -143.76 5.14 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.62 -52.7 5.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.953 . . . . 0.0 109.423 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -98.32 34.68 1.92 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -26.48 68.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.73 . . . . 0.0 109.818 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.63 -44.51 86.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.45 -0.781 . . . . 0.0 109.725 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.71 -18.04 57.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.89 -31.98 35.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 110.659 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -80.95 -38.08 28.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.368 -0.832 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.7 p30 -81.03 -26.84 36.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.248 -0.908 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.44 57.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -82.42 -32.16 29.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.01 -50.89 68.94 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -63.76 -33.55 75.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.546 -0.721 . . . . 0.0 109.606 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -61.26 -37.2 82.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mtp -65.12 -41.6 94.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.396 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -92.34 18.79 7.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.528 -0.732 . . . . 0.0 110.236 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 p -89.81 -38.01 14.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.185 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.07 -29.75 7.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.07 36.87 1.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 18' ' ' PRO . 55.2 mt -84.44 -28.93 26.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.952 . . . . 0.0 109.609 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.79 -173.6 42.5 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.599 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -177.05 -173.72 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.768 . . . . 0.0 109.556 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -173.59 -171.21 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 6' ' ' PHE . 19.2 m -139.12 160.48 39.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.753 ' CE1' HD12 ' A' ' 63' ' ' ILE . 95.0 m-85 -147.01 128.8 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 109.483 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -98.8 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.71 115.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -113.45 -22.3 10.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.528 -0.732 . . . . 0.0 109.985 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.97 144.63 38.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 0.0 109.781 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 12' ' ' SER . 1.9 p30 -63.67 163.6 11.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.594 -0.691 . . . . 0.0 109.487 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.64 -51.93 0.11 Allowed 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.69 -128.23 9.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.88 125.4 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.564 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.7 -167.59 1.82 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.67 -20.5 65.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.221 -0.925 . . . . 0.0 111.592 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -65.21 -59.47 9.8 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.959 -1.088 . . . . 0.0 109.906 -179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.8 Cg_endo -73.02 -21.32 20.85 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.353 1.369 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.71 56.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.429 -0.794 . . . . 0.0 109.516 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 23' ' ' VAL . 63.1 m -79.92 -34.46 38.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.452 -0.78 . . . . 0.0 109.17 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.85 -30.29 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.551 -0.718 . . . . 0.0 109.478 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 24.3 mt -77.06 -39.05 51.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.488 -0.758 . . . . 0.0 109.782 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.2 p -65.99 -31.02 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 109.266 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -68.26 -43.79 77.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 109.513 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -61.96 -52.93 62.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.724 . . . . 0.0 109.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.32 -17.68 64.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.0 t -64.55 -15.91 61.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.17 17.79 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -138.96 129.66 26.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.91 -0.31 34.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.516 -0.74 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.47 -174.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -110.21 99.47 8.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.493 -0.754 . . . . 0.0 109.512 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 33' ' ' VAL . 22.2 m -90.87 118.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -125.56 150.96 47.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.696 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 61' ' ' ILE . 5.3 tt -115.89 121.69 43.1 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.15 117.8 34.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.569 -0.707 . . . . 0.0 109.721 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 61' ' ' ILE . 63.3 t80 -155.19 147.12 23.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.614 -0.679 . . . . 0.0 109.826 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.93 31.25 20.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 110.001 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 37.24 94.01 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.13 143.22 40.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.693 -0.886 . . . . 0.0 109.133 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -108.5 99.72 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.38 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 m -107.35 -173.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -111.45 136.3 50.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.539 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -19.96 63.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.634 -0.666 . . . . 0.0 109.94 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' HA ' HG23 ' A' ' 23' ' ' VAL . 36.5 mtpt -84.68 7.76 19.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.36 126.99 51.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.01 -1.056 . . . . 0.0 109.434 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.89 -34.67 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.89 -22.24 25.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.605 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.37 -20.97 68.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 46' ' ' SER . 36.8 t -85.62 -32.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.252 -1.146 . . . . 0.0 109.953 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 48' ' ' MET . 8.2 p -62.12 -24.29 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.8 p -67.51 -37.15 82.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -0.776 . . . . 0.0 109.318 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.9 mt -63.72 -55.28 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.624 -0.673 . . . . 0.0 109.433 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.5 56.72 3.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 37' ' ' TYR . 45.2 mt -76.44 140.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.571 -0.958 . . . . 0.0 109.071 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -122.56 -171.03 2.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.806 -0.559 . . . . 0.0 109.668 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -63.18 158.14 20.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.57 50.71 59.86 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -128.25 118.92 24.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 109.616 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.56 114.82 25.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 37' ' ' TYR . 6.2 pt -111.69 164.87 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.615 -0.678 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 m -126.97 161.79 27.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.6 mt -138.41 141.69 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -146.09 119.68 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.512 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.88 130.93 51.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.42 108.59 8.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.31 -139.27 4.27 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.96 -54.26 3.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.937 . . . . 0.0 109.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -97.71 41.58 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -27.52 68.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -69.03 -45.88 69.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 109.943 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -75.25 -19.83 59.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.495 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.7 -36.94 31.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.724 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.9 pp -76.23 -39.25 55.02 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.614 ' N ' HD12 ' A' ' 74' ' ' LEU . 16.2 p30 -79.76 -26.03 40.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.192 -0.943 . . . . 0.0 110.064 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.22 -29.95 63.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.472 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.74 -29.01 36.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -46.78 72.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.566 -0.709 . . . . 0.0 109.972 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -77.35 -26.61 52.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.419 -0.801 . . . . 0.0 109.958 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.7 mtp -69.67 -48.18 60.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.497 -0.752 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -19.49 57.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 110.157 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -59.54 -34.2 72.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.218 -0.926 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.97 -27.03 11.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 109.778 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.18 59.69 1.09 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.1 mt -109.56 -37.8 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.648 -0.913 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.7 173.38 38.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.414 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -177.1 -172.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.625 -0.672 . . . . 0.0 109.437 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.33 -178.36 0.95 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -140.67 148.71 41.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.573 -0.705 . . . . 0.0 109.382 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 63' ' ' ILE . 62.4 m-85 -137.86 146.95 44.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.606 -0.684 . . . . 0.0 109.608 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -104.79 109.91 22.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 109.237 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 14' ' ' ILE . 23.4 t -73.21 115.0 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.631 . . . . 0.0 109.401 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 5.5 m -115.42 20.89 14.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.741 . . . . 0.0 110.081 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.77 135.97 40.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -57.6 -26.64 61.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.636 -0.665 . . . . 0.0 110.165 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 p -98.44 -29.07 13.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 109.431 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.83 -132.85 11.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 8' ' ' VAL . 65.8 mt -125.81 110.78 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.656 -0.909 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -124.62 -124.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.56 -0.713 . . . . 0.0 109.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.9 -28.88 22.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.346 -1.471 . . . . 0.0 111.371 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.7 OUTLIER -61.48 -54.72 49.73 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.172 -0.955 . . . . 0.0 109.944 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HB3' HD22 ' A' ' 86' ' ' LEU . 34.9 Cg_endo -76.96 -25.59 8.75 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 121.481 1.454 . . . . 0.0 110.59 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -72.22 -23.88 61.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.91 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 23' ' ' VAL . 35.9 m -82.43 -47.88 11.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.821 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.95 -24.32 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 22' ' ' LEU . 41.0 mt -80.92 -40.05 25.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' THR . 8.8 p -66.61 -26.2 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.433 -0.792 . . . . 0.0 109.907 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -74.97 -46.58 34.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -61.53 -39.76 92.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.727 . . . . 0.0 109.751 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.6 62.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.694 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.542 -0.724 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -65.35 -26.21 67.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.501 -0.749 . . . . 0.0 109.818 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -109.11 138.11 45.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.441 -0.787 . . . . 0.0 109.676 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.99 -3.86 57.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.678 -0.639 . . . . 0.0 110.541 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.22 178.5 0.27 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.35 98.97 9.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.555 -0.716 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.27 114.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -122.32 153.22 39.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.574 -0.704 . . . . 0.0 109.774 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.3 tp -110.32 120.75 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.694 -0.628 . . . . 0.0 109.317 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.71 111.23 23.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CD2' HG12 ' A' ' 55' ' ' ILE . 56.5 t80 -140.01 142.91 36.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.624 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.54 31.72 20.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.772 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.37 33.59 86.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -132.88 143.75 49.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.684 -0.892 . . . . 0.0 109.085 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -103.31 97.28 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.5 m -97.96 -174.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.314 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.2 134.02 41.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.857 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -67.61 -27.38 66.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.468 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -93.22 39.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.191 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -122.13 128.29 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.385 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.3 mp -94.53 -35.83 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -93.56 16.58 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.6 -34.71 4.61 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG13 HD12 ' A' ' 55' ' ' ILE . 47.8 t -69.38 -24.04 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 109.543 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.65 -39.0 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.402 -0.811 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -71.6 -30.44 65.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -69.63 -36.3 76.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.487 -0.758 . . . . 0.0 109.691 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.66 46.7 17.58 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.881 HD12 HG13 ' A' ' 50' ' ' VAL . 53.0 mt -77.93 141.48 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.81 -166.57 2.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -61.06 143.79 54.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.49 46.51 55.25 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.67 126.12 51.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.905 . . . . 0.0 109.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -86.88 113.8 22.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.396 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.68 159.56 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.619 -0.676 . . . . 0.0 109.511 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -129.38 161.61 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.74 . . . . 0.0 109.347 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 6' ' ' PHE . 79.9 mt -137.77 138.92 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.5 p -139.34 117.21 11.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.9 129.09 54.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.27 105.97 6.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.358 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.78 -143.8 5.42 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.92 -61.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.535 -0.98 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -96.67 42.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.605 -0.684 . . . . 0.0 109.337 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -26.59 67.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.1 m120 -69.74 -39.36 76.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.65 -19.55 59.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 110.194 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -37.49 29.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.297 -0.877 . . . . 0.0 110.7 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.599 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.3 pp -74.71 -35.61 62.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.167 -0.958 . . . . 0.0 110.515 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 74' ' ' LEU . 14.0 p30 -84.25 -26.61 28.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.72 -31.01 59.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.154 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.6 mt -79.09 -30.48 43.91 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.73 -50.61 66.21 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 -33.29 75.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 109.912 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 m -72.35 -27.0 62.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.544 -0.722 . . . . 0.0 110.0 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.9 mmt -67.24 -52.91 35.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -74.59 -21.05 59.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -58.76 -46.91 86.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.146 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -90.89 -60.91 1.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.49 65.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 18' ' ' PRO . 82.8 mt -110.6 -37.08 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.939 . . . . 0.0 109.571 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.44 13.49 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.592 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.49 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -171.7 -177.75 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -176.2 162.22 2.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.726 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.42 148.52 43.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.604 -0.685 . . . . 0.0 109.642 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.97 104.04 13.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.557 -0.714 . . . . 0.0 109.322 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -75.44 113.04 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.943 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.69 147.61 32.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.318 -0.864 . . . . 0.0 109.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.04 174.19 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.464 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p 76.52 -4.87 2.28 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 59.85 -133.5 51.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 13' ' ' GLY . 37.2 mm -139.59 109.68 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.68 -0.894 . . . . 0.0 109.292 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.0 p80 -123.13 -124.51 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.64 -0.662 . . . . 0.0 109.745 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.79 -29.19 24.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.211 -1.556 . . . . 0.0 111.06 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -60.25 -54.92 50.37 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.176 -0.952 . . . . 0.0 109.952 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 35.0 Cg_endo -76.85 -24.84 9.65 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 121.586 1.524 . . . . 0.0 110.564 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.4 59.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.5 m -89.32 -37.59 14.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.293 -0.879 . . . . 0.0 109.56 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -76.13 -30.71 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.426 -0.796 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.28 -37.89 31.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.654 -0.654 . . . . 0.0 110.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.3 p -66.22 -31.4 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.442 -0.786 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -69.14 -47.71 64.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.677 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -61.17 -36.91 81.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.461 -0.775 . . . . 0.0 109.97 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.53 -26.31 60.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 109.859 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -65.39 -25.27 67.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.46 -0.775 . . . . 0.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.91 -25.32 65.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.378 -0.826 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -107.37 132.45 53.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.414 -0.804 . . . . 0.0 109.881 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.8 -6.61 49.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.658 -0.651 . . . . 0.0 110.363 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.45 160.65 8.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 109.637 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.62 97.34 10.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.818 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB3' ' A' ' 44' ' ' LEU . 16.4 m -92.3 132.85 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.239 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -130.64 159.78 36.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.79 126.72 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -114.22 125.61 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.602 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 59.4 t80 -141.54 137.79 32.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.689 -0.632 . . . . 0.0 109.541 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 65.01 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.89 31.06 0.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -132.85 142.85 49.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.69 -0.888 . . . . 0.0 109.262 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -111.21 104.59 13.1 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -98.58 -176.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -98.7 137.38 37.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.715 . . . . 0.0 109.805 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.94 -26.36 64.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 23' ' ' VAL . 29.0 mtpt -84.43 10.68 10.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 111.0 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.72 126.79 52.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 109.343 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.2 mp -93.81 -31.88 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -30.61 18.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.666 . . . . 0.0 109.28 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.73 -29.66 75.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.0 p -74.13 -25.95 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.527 -0.984 . . . . 0.0 109.647 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.6 -32.18 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 109.326 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.7 p -63.66 -32.61 74.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 53' ' ' LEU . 17.1 mt -65.84 -51.68 56.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.55 57.98 5.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.95 142.2 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.613 -0.933 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.01 -173.21 2.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.777 -0.577 . . . . 0.0 109.533 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.79 158.22 30.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.618 -0.676 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.72 48.86 81.63 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -117.73 134.85 54.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -92.03 121.07 33.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.65 -0.656 . . . . 0.0 109.298 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 pt -114.83 162.45 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 m -133.95 111.14 10.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -92.31 145.26 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.575 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -144.05 112.32 6.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -105.6 137.55 43.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.58 -0.7 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -143.37 109.11 5.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.43 -131.86 1.5 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.55 -50.5 4.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -99.36 37.67 1.53 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.79 -28.54 69.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.05 -49.25 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.507 -0.745 . . . . 0.0 109.896 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.33 -17.64 62.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.8 -44.78 17.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.726 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.5 pp -69.71 -38.23 76.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.39 -0.819 . . . . 0.0 110.946 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD12 ' A' ' 74' ' ' LEU . 13.4 p30 -80.45 -26.55 38.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.32 -29.5 60.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 73' ' ' ALA . 9.3 mt -82.51 -26.05 32.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 109.237 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.49 -44.94 61.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.618 -0.676 . . . . 0.0 109.309 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -68.94 -31.43 70.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.453 -0.779 . . . . 0.0 109.671 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m -76.16 -28.13 57.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.66 71.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 109.805 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.52 -31.05 59.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.691 . . . . 0.0 109.811 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.3 p -62.49 -29.75 70.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.461 -0.774 . . . . 0.0 109.655 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.96 -27.39 16.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.482 -0.761 . . . . 0.0 109.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.59 36.56 8.57 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.63 -40.24 19.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.905 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.86 -163.24 23.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.471 -1.017 . . . . 0.0 109.517 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 42.62 -164.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.832 -0.543 . . . . 0.0 111.36 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.98 174.15 0.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -135.76 107.3 6.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.582 -0.699 . . . . 0.0 109.253 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 63' ' ' ILE . 61.2 m-85 -93.4 158.41 15.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.18 105.98 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 14' ' ' ILE . 40.3 t -68.01 119.52 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.633 -0.667 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -116.72 -12.94 10.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.675 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.01 143.32 48.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.162 -0.961 . . . . 0.0 109.771 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -65.52 166.56 10.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.721 -0.612 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 p 59.57 16.9 5.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.826 -0.546 . . . . 0.0 110.794 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.67 -122.95 31.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 8' ' ' VAL . 56.7 mt -135.54 129.29 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.684 -0.892 . . . . 0.0 109.496 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.9 p80 -121.87 -166.16 1.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.633 . . . . 0.0 109.352 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.26 -27.03 69.06 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 111.495 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 5.7 mtp180 -60.54 -60.93 9.08 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.952 -1.093 . . . . 0.0 109.942 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.2 Cg_endo -71.59 -19.39 28.18 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.346 1.364 . . . . 0.0 110.622 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.76 -24.24 56.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 m -83.4 -34.71 25.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.89 -31.84 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 mt -76.21 -44.76 36.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.592 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.7 p -62.18 -30.75 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.525 -0.734 . . . . 0.0 109.268 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.81 -45.29 82.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.57 -47.25 87.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.595 -0.691 . . . . 0.0 109.776 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -67.07 -22.11 65.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.708 . . . . 0.0 110.122 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 t -65.7 -32.05 73.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.862 . . . . 0.0 109.571 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.84 -23.67 67.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -108.17 135.41 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.443 -0.786 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.97 0.48 55.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.73 -0.606 . . . . 0.0 110.606 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.12 -178.93 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.06 -1.025 . . . . 0.0 109.369 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.33 94.87 6.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.641 ' CG1' HD22 ' A' ' 44' ' ' LEU . 25.1 t -93.16 109.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.645 -0.66 . . . . 0.0 109.305 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -116.12 145.17 43.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.818 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 42' ' ' VAL . 14.5 tp -100.59 122.17 42.82 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.89 111.34 22.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.703 . . . . 0.0 109.593 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.592 ' OH ' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -139.96 139.01 36.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.635 -0.666 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.69 37.69 22.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.539 -0.726 . . . . 0.0 109.956 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.14 30.77 71.27 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -126.4 143.76 51.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.743 -0.857 . . . . 0.0 109.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -111.07 136.93 49.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.603 -0.685 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.6 m -143.38 175.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.23 134.28 39.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.4 tp -73.29 -7.8 53.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 110.564 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -95.19 25.2 4.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 109.835 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -126.74 128.95 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.437 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.07 -38.34 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.9 tpt -78.12 -29.6 48.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.17 67.45 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.55 -27.3 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.417 -1.049 . . . . 0.0 109.805 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.87 -29.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.538 -0.726 . . . . 0.0 109.759 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 p -68.07 -34.16 75.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -71.5 -56.8 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.708 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.42 4.42 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mt -73.61 142.48 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.623 -0.928 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 177.66 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.2 156.76 38.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.572 -0.705 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.19 50.83 48.75 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.29 170.66 11.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.99 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -125.94 118.73 26.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.79 159.61 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.25 108.17 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 109.517 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 6' ' ' PHE . 62.6 mt -93.1 130.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.5 p -128.38 117.01 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.567 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.54 131.56 52.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.522 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 m -141.92 108.27 5.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 -121.07 0.71 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.28 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.94 . . . . 0.0 109.409 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -97.11 44.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.1 -31.84 72.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.566 -0.709 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -71.6 -41.41 68.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.533 -0.729 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.45 -20.01 61.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.38 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -43.35 20.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.878 . . . . 0.0 110.618 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -69.87 -42.07 73.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.321 -0.862 . . . . 0.0 110.792 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.688 ' N ' HD12 ' A' ' 74' ' ' LEU . 10.1 p30 -74.41 -27.19 60.52 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.208 -0.932 . . . . 0.0 109.836 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.14 -28.18 61.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 109.265 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 73' ' ' ALA . 8.9 mt -82.25 -24.16 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.378 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.5 -44.59 50.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.747 . . . . 0.0 109.336 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.84 -37.58 86.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.912 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.8 m -77.06 -25.83 52.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.456 -0.778 . . . . 0.0 109.882 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -46.94 61.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.443 -0.786 . . . . 0.0 110.251 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -76.9 -35.46 57.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.192 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -60.77 -28.41 68.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.36 -28.77 17.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.503 -0.748 . . . . 0.0 109.586 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.08 31.99 11.28 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.36 -34.56 13.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.644 -0.915 . . . . 0.0 109.577 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.61 -173.07 35.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.469 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -177.86 -172.89 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.72 170.23 1.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.616 -0.677 . . . . 0.0 109.2 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -121.5 140.19 52.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CE2' HD12 ' A' ' 63' ' ' ILE . 95.3 m-85 -129.95 134.85 47.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -102.76 115.38 30.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.75 121.04 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.641 -0.662 . . . . 0.0 109.464 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 9' ' ' THR . 29.0 m -122.3 -3.91 8.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.06 129.55 40.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.613 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -71.35 86.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.803 -0.561 . . . . 0.0 109.559 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p 169.27 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.69 -156.83 19.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 55' ' ' ILE . 57.5 mt -109.82 120.7 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.933 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 1.6 p80 -129.15 -165.74 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 0.0 109.355 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -21.68 65.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.042 -1.036 . . . . 0.0 111.422 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -63.89 -59.65 10.91 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.034 -1.042 . . . . 0.0 109.971 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.1 Cg_endo -71.81 -17.71 28.92 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.417 1.411 . . . . 0.0 111.115 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.65 42.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 m -79.86 -33.57 40.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.477 -0.764 . . . . 0.0 109.188 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.12 -30.03 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 109.317 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.61 -35.27 52.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.554 -0.716 . . . . 0.0 109.756 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.2 p -69.79 -31.68 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -66.7 -48.67 68.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.655 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' HG21 ' A' ' 80' ' ' THR . 20.2 m -62.82 -38.79 92.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.541 -0.724 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -70.39 -24.31 62.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.955 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 t -65.95 -26.22 67.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.0 109.787 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -24.82 66.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 109.968 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -112.85 138.36 49.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.41 -0.806 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -8.17 59.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.698 -0.626 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 158.68 8.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.101 -0.999 . . . . 0.0 109.795 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.54 96.87 10.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.58 -0.7 . . . . 0.0 109.756 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 26' ' ' ALA . 17.0 m -93.01 114.88 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -119.86 159.23 25.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 109.933 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 HD12 ' A' ' 61' ' ' ILE . 5.7 tt -118.47 128.3 54.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -109.81 120.81 43.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 109.693 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 61' ' ' ILE . 57.8 t80 -145.71 141.12 27.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.426 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 62.07 34.06 16.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.64 29.19 71.29 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -125.87 143.68 50.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.92 . . . . 0.0 108.96 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.61 117.76 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.648 . . . . 0.0 109.533 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -124.96 171.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.59 137.11 32.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.069 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.6 tt -77.7 -21.68 51.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 110.362 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -95.9 26.74 3.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.873 . . . . 0.0 110.061 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.8 t -117.61 130.11 56.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.465 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.604 HD12 ' H ' ' A' ' 47' ' ' ILE . 5.0 mp -84.27 -37.6 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 ttt -95.41 21.98 7.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.15 -40.18 1.08 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.18 -27.64 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.623 -0.927 . . . . 0.0 109.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.65 -31.9 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -62.76 -33.03 74.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 53' ' ' LEU . 35.3 mt -63.47 -49.01 75.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 55.28 7.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 14' ' ' ILE . 49.6 mt -72.94 144.49 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.668 -0.901 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.82 175.33 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.737 -0.602 . . . . 0.0 109.577 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -63.46 165.18 8.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.682 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.57 53.12 46.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.55 161.96 26.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.968 . . . . 0.0 109.643 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.18 121.5 37.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.723 . . . . 0.0 109.183 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.89 HD12 HD11 ' A' ' 35' ' ' LEU . 24.7 pt -121.1 160.27 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.714 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.7 m -129.55 118.96 22.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.408 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.694 HD12 ' CE2' ' A' ' 6' ' ' PHE . 64.1 mt -95.73 157.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 83.1 p -149.57 115.55 5.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.12 129.31 46.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.0 109.526 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -137.64 102.26 4.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.692 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.64 -133.1 1.58 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.66 -53.58 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.989 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -98.38 40.49 1.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.73 . . . . 0.0 109.406 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 1.2 pt-20 -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.532 -0.73 . . . . 0.0 109.901 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.14 -43.83 70.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.528 -0.733 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.18 -17.93 59.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 0.0 110.269 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.98 -39.35 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 0.0 110.609 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -72.48 -40.12 67.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.354 -0.841 . . . . 0.0 110.627 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.685 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -78.82 -27.44 44.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.235 -0.915 . . . . 0.0 109.871 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 -23.64 40.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.578 -0.701 . . . . 0.0 109.867 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.8 mt -81.8 -29.45 32.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 109.043 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.65 -42.72 70.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -71.55 -26.9 62.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.503 HG21 ' OG1' ' A' ' 25' ' ' THR . 42.9 m -78.3 -29.45 47.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.5 mmm -67.58 -44.57 77.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -72.64 -19.31 61.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -59.35 -29.69 67.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.268 -0.895 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -114.94 -18.6 11.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 110.19 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.52 55.38 2.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.1 mt -110.14 19.25 19.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.748 -0.854 . . . . 0.0 110.042 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.88 -171.6 21.66 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.537 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.869 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -177.12 160.18 1.72 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -147.18 161.7 40.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -115.46 125.62 53.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.667 -0.645 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 78' ' ' GLU . 79.9 m-85 -109.3 137.13 47.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 109.359 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -96.84 118.64 33.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.41 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 14' ' ' ILE . 29.8 t -86.8 106.39 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.279 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -101.66 -14.49 17.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.364 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 129.87 43.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.096 -1.003 . . . . 0.0 110.073 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.14 -27.51 68.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.61 -0.681 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.2 p -65.17 -27.78 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.463 -0.773 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.97 -153.65 25.84 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 55' ' ' ILE . 63.0 mt -112.37 113.39 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.511 -0.994 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.5 p80 -124.75 -164.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -19.77 66.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.12 -0.988 . . . . 0.0 111.402 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -66.13 -60.3 7.22 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.016 -1.053 . . . . 0.0 109.715 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -72.5 -20.8 23.28 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.355 1.37 . . . . 0.0 110.587 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.48 -26.44 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.809 . . . . 0.0 109.685 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.5 m -81.95 -32.41 30.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 t -76.42 -33.71 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.513 -0.742 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.67 -39.15 53.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.493 -0.754 . . . . 0.0 109.963 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.9 p -66.88 -30.04 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.512 -0.742 . . . . 0.0 109.442 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.48 -47.34 70.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.645 -0.659 . . . . 0.0 109.645 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 m -62.91 -39.97 96.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -69.36 -24.83 63.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.644 -0.66 . . . . 0.0 109.751 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -66.98 -19.79 65.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.42 -0.8 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -87.16 12.51 11.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.81 134.62 33.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 109.428 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.09 -5.04 59.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 110.515 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.96 -172.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.18 99.54 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.535 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 26' ' ' ALA . 27.2 m -97.77 112.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.553 -0.717 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -119.22 156.18 30.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.661 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.84 128.73 55.55 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -107.91 115.6 30.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 36.0 t80 -144.88 139.66 27.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 60.64 33.41 20.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.51 -0.744 . . . . 0.0 109.817 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.92 34.21 88.07 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 143.73 50.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.711 -0.876 . . . . 0.0 109.082 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 m -117.35 120.35 37.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.716 -0.615 . . . . 0.0 109.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -134.02 177.16 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . 53.2 t30 -79.97 123.13 27.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.2 tm? -68.89 -21.61 64.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 23' ' ' VAL . 13.5 mtpp -84.77 9.4 14.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.858 . . . . 0.0 110.77 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.48 127.06 48.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.167 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 47' ' ' ILE . 3.9 mp -78.45 -35.47 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 ttt -84.5 -26.11 28.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.594 -0.691 . . . . 0.0 109.672 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.39 -31.14 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.946 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.33 -33.14 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.448 -0.782 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -69.62 -30.76 68.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -68.06 -54.07 20.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.675 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 54.75 3.51 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 14' ' ' ILE . 44.0 mt -82.48 162.61 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.554 -0.968 . . . . 0.0 109.309 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.62 -167.64 2.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.78 -0.575 . . . . 0.0 109.48 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.88 151.46 34.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.682 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.08 59.0 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -118.72 125.45 49.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.551 -0.97 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.82 113.89 25.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 HD11 ' A' ' 63' ' ' ILE . 9.1 pt -107.99 149.76 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.3 m -125.07 111.52 15.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 61' ' ' ILE . 4.2 mp -92.08 152.79 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -145.81 122.58 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.14 132.38 44.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.653 -0.654 . . . . 0.0 109.373 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.1 m -145.45 104.04 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.38 -132.35 2.06 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.13 -63.45 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 109.385 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -97.09 41.49 1.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.51 -28.98 69.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -71.78 -37.65 70.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.551 -0.718 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -76.46 -20.56 56.89 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 110.221 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -38.66 28.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 110.503 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.869 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.9 pp -72.88 -39.93 66.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.39 -0.819 . . . . 0.0 110.529 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.648 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.7 p30 -79.02 -26.46 43.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.58 57.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.493 -0.754 . . . . 0.0 109.229 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.42 -27.21 34.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 2.2 tt0 -67.78 -42.73 81.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.685 -0.635 . . . . 0.0 109.292 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.07 -30.74 65.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -73.35 -29.08 62.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.444 -0.785 . . . . 0.0 109.589 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -36.21 71.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -90.59 20.19 4.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 110.442 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.7 p -89.92 -39.39 13.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.216 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -115.0 18.89 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.65 -0.656 . . . . 0.0 110.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.66 41.0 98.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.81 -33.31 21.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.497 -1.002 . . . . 0.0 109.368 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.68 42.42 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 176.5 167.33 0.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.375 -0.828 . . . . 0.0 109.352 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.43 159.46 44.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.72 . . . . 0.0 109.23 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -116.05 119.64 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.432 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 63' ' ' ILE . 99.3 m-85 -105.84 157.32 17.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.609 -0.682 . . . . 0.0 109.625 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -121.24 122.82 40.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.1 t -89.16 111.33 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.628 -0.67 . . . . 0.0 109.326 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -110.33 -25.11 10.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.613 -0.679 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.69 146.26 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' SER . 34.8 p-10 -64.57 171.34 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.672 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 3.5 p 84.44 -46.19 0.09 Allowed 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 122.58 0.352 . . . . 0.0 110.236 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.52 -124.72 8.25 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 55' ' ' ILE . 59.2 mt -130.59 113.27 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.914 . . . . 0.0 109.337 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -119.21 -169.54 1.76 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.628 -0.67 . . . . 0.0 109.387 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.65 -22.54 66.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 111.201 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 16.4 ttm180 -64.12 -58.65 13.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.116 -0.99 . . . . 0.0 109.669 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -70.22 -19.44 33.92 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 121.061 1.174 . . . . 0.0 110.509 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.36 -26.55 55.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.558 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.5 m -80.02 -34.89 38.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.307 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.43 -29.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.226 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 17.9 mt -76.0 -40.38 53.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG23 ' CB ' ' A' ' 45' ' ' LYS . 8.7 p -65.42 -31.37 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.438 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.0 -44.29 80.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.655 -0.653 . . . . 0.0 109.752 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -64.99 -38.86 92.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.706 . . . . 0.0 109.829 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -26.68 66.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.926 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 t -65.15 -26.47 68.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.435 -0.791 . . . . 0.0 109.871 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.69 -24.99 64.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 110.008 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -109.9 134.56 51.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.38 -0.825 . . . . 0.0 109.749 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.53 -8.42 57.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.56 162.05 8.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.111 -0.993 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -90.28 100.34 13.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.676 . . . . 0.0 109.586 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG12 HD13 ' A' ' 44' ' ' LEU . 40.8 t -89.87 120.67 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.253 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -125.52 150.58 47.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' A' ' 61' ' ' ILE . 27.1 tp -109.87 128.77 55.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.95 120.54 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 109.638 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 47.0 t80 -148.16 136.33 21.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.781 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 59.41 38.88 22.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.55 -0.719 . . . . 0.0 110.087 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.69 29.74 70.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' HD21 ' A' ' 53' ' ' LEU . 7.2 mtpt -122.89 144.56 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 108.896 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -123.16 119.92 31.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -132.7 176.67 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' VAL . 65.5 t30 -82.13 124.62 30.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.417 -0.802 . . . . 0.0 109.396 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD13 HG12 ' A' ' 33' ' ' VAL . 5.5 tt -61.28 -19.54 61.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.538 -0.726 . . . . 0.0 110.07 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' CB ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -95.13 41.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -127.13 131.81 50.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.03 -36.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.8 ttt -87.41 -29.9 21.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.77 -0.581 . . . . 0.0 109.54 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.33 -34.23 84.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.78 -26.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -1.019 . . . . 0.0 110.051 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.5 -29.97 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.1 p -72.67 -28.44 62.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.478 -0.764 . . . . 0.0 109.817 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 40' ' ' LYS . 6.3 mt -68.03 -53.07 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.739 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 58.18 3.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 14' ' ' ILE . 42.6 mt -86.85 142.36 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.582 -0.952 . . . . 0.0 109.474 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.31 -168.51 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 158.73 22.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.381 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.56 52.47 48.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -122.56 123.09 40.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.618 -0.93 . . . . 0.0 109.694 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.48 115.06 24.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.511 -0.743 . . . . 0.0 109.465 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' HB ' HD11 ' A' ' 35' ' ' LEU . 15.7 pt -108.93 155.14 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -131.09 114.54 15.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 6' ' ' PHE . 78.2 mt -91.97 150.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.1 p -145.02 113.51 6.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.583 -0.698 . . . . 0.0 109.267 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.46 132.62 46.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -132.26 100.97 5.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.1 -135.73 2.09 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 -47.28 5.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.689 -0.889 . . . . 0.0 109.475 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -100.94 37.12 1.8 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.51 -29.43 70.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.5 m120 -70.16 -38.37 75.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.483 -0.761 . . . . 0.0 109.601 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -76.52 -22.66 54.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.013 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.69 -42.4 41.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.869 . . . . 0.0 110.51 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.7 pp -68.72 -43.55 75.73 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.363 -0.836 . . . . 0.0 110.717 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.701 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.1 p30 -75.47 -27.32 58.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.069 -1.02 . . . . 0.0 109.813 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 -25.21 54.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 109.492 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.82 -23.65 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.772 . . . . 0.0 109.459 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.89 -39.96 55.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.769 . . . . 0.0 109.21 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -74.67 -28.26 60.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.056 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 m -84.96 -26.17 27.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.025 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.82 -44.07 74.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.746 . . . . 0.0 109.767 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.68 -24.21 61.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 110.096 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.9 p -60.1 -28.74 68.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.283 -0.886 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -103.01 -27.19 12.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.61 41.41 5.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.19 -36.26 10.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.954 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.2 172.94 41.67 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.635 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.321 0.582 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -176.37 173.95 2.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.6 -0.688 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.59 174.25 10.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.392 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -115.48 135.27 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 0.0 109.273 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' CE1' HD12 ' A' ' 63' ' ' ILE . 26.0 m-85 -119.52 171.45 8.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 0.0 109.77 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -140.39 113.44 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' ILE . 32.8 t -65.93 124.43 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.695 . . . . 0.0 109.146 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -123.56 -3.83 8.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.631 -0.668 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.2 136.23 39.73 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.607 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -71.19 86.78 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.621 . . . . 0.0 109.533 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p 169.37 -34.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.11 -152.97 21.59 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.8 mt -123.21 103.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.609 -0.936 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.7 p80 -122.23 -127.09 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.668 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.86 -30.22 26.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.311 -1.493 . . . . 0.0 111.656 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 2.5 ttt180 -62.16 -55.28 42.01 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.068 -1.02 . . . . 0.0 110.013 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 35.0 Cg_endo -76.96 -20.07 13.4 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.459 1.439 . . . . 0.0 110.828 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -75.54 -27.41 58.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.5 m -81.54 -35.73 29.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' OE2' ' A' ' 84' ' ' GLU . 29.2 t -76.51 -26.72 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.722 . . . . 0.0 109.474 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' PRO . 33.7 mt -82.26 -36.36 27.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 0.0 109.842 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG23 ' CB ' ' A' ' 45' ' ' LYS . 9.7 p -69.04 -32.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -70.62 -47.32 60.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 110.07 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.7 m -61.23 -47.15 87.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.503 -0.748 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -66.09 -23.77 66.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.599 -0.688 . . . . 0.0 110.054 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.437 -0.789 . . . . 0.0 109.676 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -64.45 -27.13 68.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.508 -0.745 . . . . 0.0 109.902 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -105.42 136.51 44.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.698 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.87 5.28 41.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.67 -0.644 . . . . 0.0 110.372 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 -165.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -115.08 98.38 6.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.719 . . . . 0.0 109.638 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 ' HB1' ' A' ' 26' ' ' ALA . 15.8 m -93.98 126.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.37 150.95 51.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 61' ' ' ILE . 8.1 tt -112.87 129.13 56.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.36 128.92 54.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.678 . . . . 0.0 109.775 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.611 ' HB3' HD22 ' A' ' 53' ' ' LEU . 18.7 t80 -160.28 142.89 13.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.667 -0.646 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m120 56.17 28.76 13.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.439 -0.788 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.85 42.98 94.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -144.06 143.75 31.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.704 -0.88 . . . . 0.0 108.992 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 m -114.34 127.73 56.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.641 -0.662 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.94 -175.66 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.571 -0.706 . . . . 0.0 109.421 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.52 120.32 32.87 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 tp -58.36 -23.73 57.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' CB ' HG23 ' A' ' 23' ' ' VAL . 34.3 mtpt -95.17 40.9 1.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 t -128.95 131.03 47.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.455 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.4 mp -81.28 -37.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.549 ' C ' HG22 ' A' ' 51' ' ' VAL . 7.1 ttt -95.52 20.48 9.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.698 -0.626 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.57 -59.4 1.21 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 55' ' ' ILE . 35.3 t -67.56 -17.45 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.635 -0.921 . . . . 0.0 110.107 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG22 ' C ' ' A' ' 48' ' ' MET . 34.8 m -57.03 -29.11 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 109.968 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -79.26 -33.68 43.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 37' ' ' TYR . 50.9 mt -64.51 -37.22 86.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.638 -0.664 . . . . 0.0 109.531 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.55 51.56 25.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 50' ' ' VAL . 44.9 mt -77.56 140.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.553 -0.969 . . . . 0.0 109.262 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.12 -176.1 4.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.21 17.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.497 -0.752 . . . . 0.0 109.853 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 52.56 45.54 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 37' ' ' TYR . . . -125.72 164.6 20.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.967 . . . . 0.0 109.782 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.14 119.2 24.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -112.81 176.58 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.466 -0.771 . . . . 0.0 109.533 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -140.65 110.65 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD12 ' CE1' ' A' ' 6' ' ' PHE . 69.5 mt -91.89 146.25 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.091 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 p -145.2 130.76 18.84 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.19 142.41 45.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.493 -0.755 . . . . 0.0 109.8 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 m -149.83 107.99 3.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.711 -0.618 . . . . 0.0 109.393 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.34 -140.96 5.85 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.3 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.486 -1.008 . . . . 0.0 109.409 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -95.74 45.48 1.08 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 109.274 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.27 -30.24 70.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.733 . . . . 0.0 109.696 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -70.14 -45.61 66.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.618 -0.676 . . . . 0.0 109.686 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 39.3 m-20 -71.03 -19.02 62.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 110.424 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -45.33 17.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.659 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -68.8 -39.33 80.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.691 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.3 p30 -79.74 -25.77 40.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.237 -0.914 . . . . 0.0 110.294 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -75.38 -32.0 60.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mt -79.61 -27.28 41.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -66.72 -50.36 63.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.957 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 m -70.92 -26.61 63.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.56 -0.713 . . . . 0.0 110.002 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 tpp -69.51 -45.34 69.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.157 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -77.17 -23.99 51.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.154 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.1 p -61.39 -45.12 95.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.357 -0.839 . . . . 0.0 109.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE2' HG11 ' A' ' 21' ' ' VAL . 11.5 mt-10 -86.53 -29.4 22.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.561 -0.712 . . . . 0.0 109.94 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.61 30.33 7.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.94 -34.53 29.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.945 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -175.07 38.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.251 0.548 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -173.37 -172.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.524 -0.735 . . . . 0.0 109.335 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.57 172.92 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.601 -0.687 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -131.2 135.18 47.18 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.8 m-85 -124.08 151.77 43.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.543 -0.723 . . . . 0.0 109.888 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -106.79 103.89 13.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.602 -0.686 . . . . 0.0 109.285 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.94 118.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -119.54 -10.03 9.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.669 -0.644 . . . . 0.0 110.442 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.82 122.02 12.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 109.986 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -71.27 86.27 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.225 0.536 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p 169.34 -34.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.11 -159.85 15.46 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -120.06 107.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.938 . . . . 0.0 109.58 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p80 -123.35 -124.93 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.67 . . . . 0.0 109.582 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.37 -29.1 23.2 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.305 -1.497 . . . . 0.0 111.245 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 9.9 mtp85 -61.23 -54.57 52.17 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.145 -0.972 . . . . 0.0 110.054 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 34.9 Cg_endo -77.24 -24.94 8.98 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 121.532 1.488 . . . . 0.0 110.746 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.93 -18.57 58.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.5 m -88.7 -37.98 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.63 -27.82 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.0 -34.96 32.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.541 -0.724 . . . . 0.0 109.834 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -70.15 -30.44 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.513 -0.742 . . . . 0.0 109.628 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -71.57 -48.62 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -60.57 -47.01 88.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 109.874 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -63.57 -32.56 74.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.714 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -27.33 68.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.69 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -65.9 -24.04 66.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -107.61 133.17 52.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.364 -0.835 . . . . 0.0 109.704 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.81 -15.64 62.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.699 -0.626 . . . . 0.0 110.306 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.85 162.69 3.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 109.766 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -89.87 105.95 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.685 -0.634 . . . . 0.0 109.595 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.17 118.38 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -120.78 161.56 21.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.7 . . . . 0.0 109.654 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 44' ' ' LEU . 7.2 tp -118.71 130.27 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -110.11 127.47 54.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.519 -0.738 . . . . 0.0 109.631 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.719 ' HB3' HD22 ' A' ' 53' ' ' LEU . 47.8 t80 -156.49 139.97 15.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.597 -0.689 . . . . 0.0 109.817 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.45 34.46 18.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.588 -0.695 . . . . 0.0 109.943 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.56 30.11 68.0 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -128.26 143.4 51.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.882 . . . . 0.0 108.991 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.74 131.42 48.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.648 -0.657 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.5 m -137.03 -173.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -108.39 135.17 50.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 35' ' ' LEU . 40.0 tp -69.14 -19.63 64.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.615 -0.678 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.716 ' HA ' HG23 ' A' ' 23' ' ' VAL . 32.3 mtmt -96.2 30.2 2.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.14 129.71 53.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.7 mp -88.06 -35.93 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.57 -0.706 . . . . 0.0 109.247 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.13 -28.33 25.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.662 -0.649 . . . . 0.0 109.517 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.07 97.35 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 53' ' ' LEU . 9.4 p -69.8 -33.55 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.945 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.9 t -62.41 -34.26 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.763 . . . . 0.0 109.477 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.5 p -67.49 -31.0 70.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 37' ' ' TYR . 8.0 mt -65.82 -43.06 89.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.595 -0.691 . . . . 0.0 109.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 49.7 5.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 37' ' ' TYR . 51.6 mt -76.38 142.12 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.984 . . . . 0.0 109.243 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.73 175.39 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.788 -0.57 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -59.82 151.86 24.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.604 -0.685 . . . . 0.0 109.942 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.32 53.66 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.91 171.85 9.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.97 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -127.63 131.64 49.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG22 ' CD1' ' A' ' 37' ' ' TYR . 3.8 pt -129.3 167.18 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.605 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -135.98 116.93 14.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.594 -0.691 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 6' ' ' PHE . 85.1 mt -91.93 156.55 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.74 . . . . 0.0 109.476 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 p -146.01 142.34 28.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.656 -0.652 . . . . 0.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.72 48.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -142.53 99.43 3.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.638 -0.664 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.44 -143.74 5.32 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -51.46 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.75 40.76 1.28 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.34 -27.67 69.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.64 -0.663 . . . . 0.0 109.748 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -75.11 -46.86 31.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.634 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -67.66 -17.9 64.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -50.8 9.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -64.07 -43.24 96.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.369 -0.832 . . . . 0.0 110.933 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.708 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.5 p30 -74.04 -26.77 60.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.156 -0.965 . . . . 0.0 109.933 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.5 -27.27 63.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 109.339 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.03 -27.28 35.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.9 -50.38 66.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -31.14 70.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 109.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.3 m -70.75 -28.84 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 0.0 109.747 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -65.7 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.681 . . . . 0.0 109.92 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -59.62 -25.63 64.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -65.48 -36.25 83.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.427 -0.796 . . . . 0.0 109.575 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -104.9 1.49 28.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.631 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 56.96 12.43 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.38 -34.16 5.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.606 -0.938 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.27 -174.42 22.84 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.667 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -179.73 158.56 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.363 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -138.83 174.25 10.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 109.304 179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -129.48 127.18 40.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.393 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 73.8 m-85 -121.29 143.54 49.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.37 128.67 45.51 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG2' HD11 ' A' ' 14' ' ' ILE . 28.9 t -89.15 125.92 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 109.615 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' THR . 6.4 m -134.35 22.39 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.646 -0.659 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 164.03 7.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.385 -0.822 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.16 -26.86 64.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.684 . . . . 0.0 110.003 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 p -110.78 -56.32 2.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.508 -0.745 . . . . 0.0 109.885 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.94 -129.07 2.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.613 HD11 ' CG2' ' A' ' 8' ' ' VAL . 52.1 mt -140.82 88.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.968 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 11.0 p80 -108.0 -141.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.618 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.03 78.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.626 -1.296 . . . . 0.0 112.465 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 1.1 mtt-85 -53.61 -56.22 27.17 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.956 -1.09 . . . . 0.0 111.323 -178.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 33.4 Cg_endo -73.97 -21.66 18.14 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.326 1.351 . . . . 0.0 110.732 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -76.62 -19.57 57.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 109.682 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 23' ' ' VAL . 34.4 m -87.31 -36.29 17.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.2 -33.69 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.592 -0.692 . . . . 0.0 109.152 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 mt -76.82 -44.41 32.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.539 -0.726 . . . . 0.0 109.783 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -62.07 -29.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.782 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -69.15 -44.75 71.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.748 -0.595 . . . . 0.0 109.626 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.0 m -61.38 -41.71 97.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.707 . . . . 0.0 109.905 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.892 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -73.72 -23.79 59.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.0 110.036 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -67.0 -28.75 68.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.404 -0.81 . . . . 0.0 109.71 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -61.21 -23.92 65.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.043 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.92 135.87 48.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -80.04 -3.04 46.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 109.657 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.95 97.74 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.656 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.892 HG21 ' HB1' ' A' ' 26' ' ' ALA . 16.4 m -93.43 131.52 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 109.421 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -133.46 159.37 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.715 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 63' ' ' ILE . 3.2 tp -123.79 128.36 49.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.703 -0.623 . . . . 0.0 109.35 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -106.04 119.64 39.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.581 -0.699 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' CD1' HG22 ' A' ' 61' ' ' ILE . 59.2 t80 -154.72 145.36 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.579 -0.701 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.74 29.66 19.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.504 -0.748 . . . . 0.0 109.767 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.33 34.83 90.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -135.79 142.46 44.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.714 -0.874 . . . . 0.0 109.281 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -110.25 106.01 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 43' ' ' ASN . 1.7 t -111.9 177.34 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' H ' HG12 ' A' ' 42' ' ' VAL . 54.1 t30 -89.1 133.25 34.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.478 -0.764 . . . . 0.0 109.538 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HG23 ' A' ' 33' ' ' VAL . 48.2 tp -71.32 -14.68 62.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.648 -0.657 . . . . 0.0 110.046 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.3 mttt -94.45 25.46 3.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -123.77 126.39 46.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.865 . . . . 0.0 109.287 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.586 HD12 ' H ' ' A' ' 47' ' ' ILE . 4.6 mp -79.78 -38.86 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.0 tpt -77.97 -27.99 49.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.549 -0.719 . . . . 0.0 109.382 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -29.68 73.09 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 t -85.02 -29.19 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.974 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.0 t -62.15 -34.04 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.4 p -65.29 -29.32 70.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.678 . . . . 0.0 109.681 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 53' ' ' LEU . 52.0 mt -75.94 -45.67 33.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.66 55.53 11.51 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 14' ' ' ILE . 62.9 mt -69.11 143.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.534 -0.98 . . . . 0.0 109.234 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.76 174.37 8.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.789 -0.569 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 156.31 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.915 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.96 51.36 51.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -126.98 170.03 12.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.964 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.62 123.23 38.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.673 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 37' ' ' TYR . 28.5 pt -128.18 155.57 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.62 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -131.96 121.84 24.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.626 -0.671 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 35' ' ' LEU . 4.0 mp -92.37 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 63' ' ' ILE . 1.3 p -149.87 120.3 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.72 138.9 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.696 . . . . 0.0 109.648 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.8 m -149.89 99.55 2.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.654 . . . . 0.0 109.396 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.18 -140.93 3.51 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.16 -57.26 2.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.971 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -99.45 35.4 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 109.483 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -29.14 70.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.708 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.9 m120 -67.04 -39.96 87.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.71 -19.13 59.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.463 -0.773 . . . . 0.0 110.337 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.84 -41.21 23.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 110.533 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -70.06 -38.68 75.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 110.618 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.522 ' N ' HD12 ' A' ' 74' ' ' LEU . 11.8 p30 -80.43 -27.11 38.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.78 -26.65 57.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.747 . . . . 0.0 109.427 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 73' ' ' ALA . 19.0 mt -82.61 -27.41 31.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.355 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -44.09 69.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.553 -0.717 . . . . 0.0 109.354 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -72.07 -30.52 65.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -75.3 -28.72 59.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.783 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.28 -45.65 62.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.706 . . . . 0.0 109.638 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -77.5 -20.22 54.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.583 -0.698 . . . . 0.0 110.074 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -59.34 -27.56 66.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.216 -0.927 . . . . 0.0 110.049 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -111.71 -28.88 7.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.45 -0.781 . . . . 0.0 109.729 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.72 32.62 5.6 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.93 -38.86 22.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.957 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.09 -179.7 35.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.617 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.173 0.511 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -179.75 -179.51 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -173.56 163.01 4.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.409 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.34 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD1' HD12 ' A' ' 63' ' ' ILE . 62.9 m-85 -118.25 160.62 21.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.533 -0.73 . . . . 0.0 109.639 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.37 112.76 22.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.55 115.06 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 9' ' ' THR . 22.7 m -110.07 26.24 10.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.87 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 154.85 14.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.728 . . . . 0.0 109.696 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.14 -27.55 65.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.9 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -103.23 -47.13 4.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.26 -136.81 8.15 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.086 HD12 HG21 ' A' ' 55' ' ' ILE . 23.4 mt -114.26 115.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.984 . . . . 0.0 109.254 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -128.61 -167.22 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 47' ' ' ILE . . . -67.07 -19.33 65.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.1 OUTLIER -64.96 -60.15 8.66 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.038 -1.039 . . . . 0.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.3 Cg_endo -70.96 -22.4 26.63 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.271 1.314 . . . . 0.0 110.465 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.27 -24.69 57.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.492 -0.755 . . . . 0.0 109.402 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.51 HG22 ' NE2' ' A' ' 24' ' ' GLN . 74.4 m -80.6 -32.74 36.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.36 -0.838 . . . . 0.0 109.123 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -76.94 -32.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.593 -0.692 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 22' ' ' LEU . 16.4 mt -77.5 -36.39 52.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.5 p -70.5 -29.81 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.468 -0.77 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.51 ' NE2' HG22 ' A' ' 20' ' ' THR . 31.2 mt-30 -67.58 -51.21 53.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 109.958 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -63.78 -40.39 96.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.767 . . . . 0.0 110.048 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.831 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -71.85 -21.52 61.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.442 -0.786 . . . . 0.0 110.32 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 p -66.12 -31.5 72.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -65.19 -23.0 66.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.54 -0.725 . . . . 0.0 110.199 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 50.9 m-85 -100.93 134.87 43.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.93 -10.55 59.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.724 -0.61 . . . . 0.0 110.347 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.69 162.39 4.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.984 -1.072 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -89.89 99.86 12.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.693 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG21 ' HB1' ' A' ' 26' ' ' ALA . 14.8 m -95.49 128.02 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -133.14 150.96 52.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 109.765 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 61' ' ' ILE . 9.4 tp -110.26 126.81 54.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.637 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -115.45 147.42 40.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.59 -0.693 . . . . 0.0 109.629 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.661 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 38.6 t80 -159.49 134.51 8.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.5 t30 65.53 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.49 30.48 0.36 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.97 143.17 49.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.881 . . . . 0.0 109.19 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -117.09 132.75 56.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.96 154.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.552 -0.717 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.33 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.641 -0.662 . . . . 0.0 109.292 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt -69.38 -11.07 60.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.8 mttt -96.36 30.46 2.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.147 -0.971 . . . . 0.0 109.91 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -120.35 130.15 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.478 -0.764 . . . . 0.0 109.361 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 47' ' ' ILE . 5.0 mp -94.33 -31.6 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.202 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.4 ttm -92.78 -29.46 15.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.391 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.1 -28.1 73.66 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' SER . 32.9 t -83.96 -37.8 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -1.037 . . . . 0.0 109.522 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.0 t -66.74 -28.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 p -63.29 -27.74 69.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.508 -0.745 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.49 -41.22 93.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 109.692 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.9 46.18 6.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 14' ' ' ILE . 44.6 mt -83.02 143.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.548 -0.972 . . . . 0.0 109.062 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -121.65 -175.48 3.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.89 152.65 26.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 109.735 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.21 50.07 29.67 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -126.67 129.24 48.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.929 . . . . 0.0 109.469 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.27 124.46 35.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.611 -0.68 . . . . 0.0 109.491 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 35' ' ' LEU . 28.5 pt -106.67 156.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.1 109.3 14.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.603 -0.686 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 6' ' ' PHE . 14.8 mt -92.63 142.3 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.698 -0.626 . . . . 0.0 109.429 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 116.48 11.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.01 133.37 53.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.723 . . . . 0.0 109.585 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.5 m -144.06 107.87 4.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.5 -131.6 1.54 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.86 -57.32 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.941 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -98.38 35.52 1.77 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -32.78 72.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 109.722 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 74' ' ' LEU . 5.0 m120 -67.29 -42.33 83.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 109.805 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.43 -18.93 60.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -0.774 . . . . 0.0 110.334 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.98 -38.99 26.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.2 pp -74.93 -35.91 62.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.294 -0.879 . . . . 0.0 110.823 -178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.6 p30 -82.86 -26.62 31.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.21 41.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -80.92 -27.74 36.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.757 . . . . 0.0 109.138 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.19 -52.51 40.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.627 -0.67 . . . . 0.0 109.193 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.13 -32.26 73.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.702 . . . . 0.0 109.601 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 -26.91 62.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.491 -0.756 . . . . 0.0 109.528 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 tpp -67.63 -38.85 84.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -78.25 -28.07 47.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.709 . . . . 0.0 109.969 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.7 p -60.31 -28.15 67.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.357 -0.839 . . . . 0.0 109.898 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.7 -27.15 12.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.521 -0.737 . . . . 0.0 109.777 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.09 50.34 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.5 -36.89 7.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.914 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.74 175.85 42.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.464 -179.923 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 179.92 156.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.53 177.69 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -125.51 126.19 44.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.514 -0.741 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 63' ' ' ILE . 53.0 m-85 -111.98 149.53 31.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.703 . . . . 0.0 109.611 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -105.79 109.9 22.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.695 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.46 118.81 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 9' ' ' THR . 6.9 m -119.83 22.53 11.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 151.97 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.44 -25.14 63.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.479 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 p -131.26 31.46 4.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.44 -148.98 34.72 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 55' ' ' ILE . 59.2 mt -115.86 120.44 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.597 -0.943 . . . . 0.0 109.866 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 1.3 p80 -110.93 -168.71 1.34 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.11 66.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.174 -0.954 . . . . 0.0 111.149 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 1.1 ttt-85 -67.81 -58.42 8.18 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.001 -1.062 . . . . 0.0 109.859 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.707 ' HB3' HD22 ' A' ' 86' ' ' LEU . 33.7 Cg_endo -70.9 -21.16 28.56 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.129 1.219 . . . . 0.0 110.534 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.02 -27.13 57.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 109.423 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -80.41 -31.45 37.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.547 -0.72 . . . . 0.0 109.242 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 t -78.03 -31.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.179 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 mt -75.52 -40.94 56.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.636 -0.665 . . . . 0.0 109.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 45' ' ' LYS . 13.5 p -67.27 -28.62 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -71.52 -36.36 71.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.528 -0.732 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' HD21 ' A' ' 77' ' ' LEU . 29.3 m -71.54 -48.52 48.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.975 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -30.32 71.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 109.885 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.8 p -67.07 -27.65 67.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.529 -0.732 . . . . 0.0 109.558 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.62 -24.0 66.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.491 -0.756 . . . . 0.0 109.963 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -111.93 132.82 54.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -8.79 56.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.754 -0.592 . . . . 0.0 110.471 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.05 163.75 3.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.073 -1.017 . . . . 0.0 109.584 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.52 99.77 12.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 109.782 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG12 HD13 ' A' ' 44' ' ' LEU . 22.4 t -96.0 118.82 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.13 141.14 49.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.75 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.28 123.96 43.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -104.73 115.98 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.443 -0.785 . . . . 0.0 109.695 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 66.2 t80 -143.16 141.31 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.68 -0.637 . . . . 0.0 109.679 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.24 33.48 20.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 109.913 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.92 83.57 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -130.48 143.86 51.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.792 -0.829 . . . . 0.0 108.906 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 m -108.68 114.28 27.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.71 -0.619 . . . . 0.0 109.771 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 53' ' ' LEU . 23.4 m -121.03 162.25 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.327 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -76.09 148.91 37.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 44' ' ' LEU . 1.4 tt -94.76 44.48 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HA ' HG23 ' A' ' 23' ' ' VAL . 23.1 mttm -139.2 19.72 2.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.925 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 t -132.0 130.1 40.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB3' ' A' ' 19' ' ' ALA . 8.3 mm -82.4 -41.84 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.825 0.821 . . . . 0.0 108.865 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -26.75 58.0 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.05 -25.99 68.64 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.38 -22.91 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.462 -1.022 . . . . 0.0 109.761 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.28 -35.82 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 109.643 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 p -64.8 -32.72 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 42' ' ' VAL . 84.1 mt -66.34 -36.75 83.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.668 . . . . 0.0 109.412 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.3 52.72 29.62 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 14' ' ' ILE . 50.6 mt -74.39 141.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.601 -0.94 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.03 -178.41 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 149.7 35.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.752 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.93 51.38 51.77 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -111.69 156.86 21.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.651 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -113.47 115.12 27.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.34 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -117.61 160.08 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.47 -0.768 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 m -133.68 114.93 14.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.414 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 6' ' ' PHE . 71.1 mt -92.22 133.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.526 -0.734 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.9 p -132.05 108.23 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.64 133.83 48.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.496 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.6 m -145.28 104.08 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.87 -131.31 1.31 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.97 -52.56 3.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.572 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -101.51 34.75 2.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.5 -27.26 68.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.713 . . . . 0.0 109.781 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.1 -42.52 93.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.498 -0.751 . . . . 0.0 109.42 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -74.98 -18.3 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.54 30.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.21 -0.931 . . . . 0.0 110.757 -179.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.0 -35.59 61.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.25 -0.907 . . . . 0.0 110.654 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -84.38 -26.86 28.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.148 -0.97 . . . . 0.0 109.991 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.15 50.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 109.418 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 25' ' ' THR . 15.7 mt -83.35 -29.91 27.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.489 -0.757 . . . . 0.0 109.073 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.73 -42.3 91.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.664 -0.648 . . . . 0.0 109.547 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -28.83 56.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.0 m -71.81 -30.36 65.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 mtt -71.33 -49.68 40.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.731 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -74.89 -12.25 60.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -58.63 -40.35 83.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 109.882 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -104.61 -36.26 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.54 39.99 1.28 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 18' ' ' PRO . 7.8 mt -82.58 -38.91 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.634 -0.921 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.69 -164.46 14.31 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -172.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.5 -0.75 . . . . 0.0 109.734 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -173.27 170.68 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.45 153.83 39.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 63' ' ' ILE . 96.4 m-85 -144.47 139.61 28.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.6 109.95 22.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.36 124.99 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 m -128.06 19.09 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 110.004 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.12 143.23 37.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -68.51 -23.77 64.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.588 -0.695 . . . . 0.0 110.122 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.0 p -100.83 12.19 38.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.377 -0.827 . . . . 0.0 110.564 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.91 -136.07 51.5 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -135.66 105.87 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.959 . . . . 0.0 109.509 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 6.9 p80 -120.09 -127.57 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.686 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.52 27.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.367 -1.458 . . . . 0.0 111.661 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -61.81 -55.31 42.94 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.162 -0.961 . . . . 0.0 109.977 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' HG12 ' A' ' 21' ' ' VAL . 35.3 Cg_endo -76.68 -19.59 14.34 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.491 1.461 . . . . 0.0 110.83 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 15' ' ' HIS . . . -76.52 -25.92 54.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.9 m -83.38 -37.31 23.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.462 -0.774 . . . . 0.0 109.469 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 18' ' ' PRO . 11.6 p -75.05 -29.37 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.458 -0.776 . . . . 0.0 109.323 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.02 -41.81 41.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 45' ' ' LYS . 8.5 p -63.26 -30.96 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.391 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -67.92 -45.92 73.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.61 -0.681 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -49.7 76.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.0 66.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.474 -0.766 . . . . 0.0 110.289 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -65.2 -26.54 68.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.85 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -68.78 -24.78 64.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.431 -0.793 . . . . 0.0 110.125 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -109.89 135.76 50.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.392 -0.818 . . . . 0.0 109.821 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.19 4.91 43.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.634 -0.666 . . . . 0.0 110.424 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -165.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 109.249 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.33 96.38 6.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.52 -0.738 . . . . 0.0 109.73 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.53 107.44 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.664 -0.648 . . . . 0.0 109.256 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -115.27 152.2 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.616 -0.677 . . . . 0.0 109.774 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.27 126.31 55.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.91 112.54 25.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.517 -0.739 . . . . 0.0 109.685 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 61.1 t80 -142.89 137.17 29.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.907 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.55 36.09 22.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.54 -0.725 . . . . 0.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.43 32.06 79.69 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -125.99 144.17 50.81 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.746 -0.856 . . . . 0.0 109.047 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -116.18 100.96 8.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.686 -0.634 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.12 -173.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -92.66 122.63 35.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.7 tt -60.59 -20.99 62.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.634 -0.666 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 23' ' ' VAL . 9.3 mtpt -95.02 37.19 1.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.852 . . . . 0.0 109.965 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -121.27 129.25 53.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -95.43 -37.95 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.1 ttt -87.62 -14.77 39.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.711 -0.618 . . . . 0.0 110.091 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.48 -27.43 27.43 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.39 -23.93 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 109.961 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 48' ' ' MET . 12.5 p -66.51 -28.24 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.367 -0.833 . . . . 0.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -63.46 -34.97 78.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.538 -0.726 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD22 ' HB3' ' A' ' 37' ' ' TYR . 2.5 mp -71.45 -53.83 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.81 55.61 3.54 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 37' ' ' TYR . 64.1 mt -68.13 142.67 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.64 -0.918 . . . . 0.0 109.217 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.81 -179.41 4.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.842 -0.536 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -64.87 155.68 33.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.687 . . . . 0.0 109.701 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.67 52.71 43.62 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -122.25 175.96 6.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.676 -0.897 . . . . 0.0 109.813 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.36 132.57 39.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 109.276 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.08 155.73 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.565 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -128.75 116.91 20.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.701 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 6' ' ' PHE . 53.8 mt -92.24 145.1 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.708 . . . . 0.0 109.466 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -136.35 119.38 16.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.662 -0.649 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.6 127.26 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -141.26 101.48 4.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.6 -133.86 2.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.64 -59.73 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.587 -0.949 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -96.06 42.57 1.09 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.633 -0.667 . . . . 0.0 109.443 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.38 -39.57 87.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.56 -0.713 . . . . 0.0 109.966 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.6 m120 -63.03 -36.2 82.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.516 -0.74 . . . . 0.0 109.928 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -77.43 -23.31 50.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.53 -37.62 50.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.667 ' CD2' ' HB1' ' A' ' 2' ' ' ALA . 3.2 pp -74.77 -37.79 62.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.879 . . . . 0.0 110.797 -178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.5 p30 -81.79 -26.21 34.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.07 -27.17 54.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.91 -26.02 31.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.531 -0.73 . . . . 0.0 109.196 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -40.78 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.579 -0.701 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.58 -28.73 61.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 m -78.33 -26.87 47.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.849 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.3 mmm -70.8 -44.41 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.571 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -76.08 -15.39 60.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.1 p -59.15 -47.06 86.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.184 -0.947 . . . . 0.0 109.93 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' OE2' HG21 ' A' ' 21' ' ' VAL . 29.6 mt-10 -96.34 -30.28 13.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.611 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.37 62.23 0.8 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.14 -38.06 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.608 -0.936 . . . . 0.0 109.417 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 167.74 35.23 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.425 -179.996 . . . . . . . . 1 1 . 1 stop_ save_